Gene Symbol | Gene ID | Gene Info |
---|---|---|
CXXC1
|
ENSG00000154832.10 | CXXC finger protein 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr18_47824525_47824817 | CXXC1 | 9997 | 0.151615 | 0.93 | 2.9e-04 | Click! |
chr18_47813109_47813489 | CXXC1 | 641 | 0.658430 | 0.89 | 1.4e-03 | Click! |
chr18_47824870_47825170 | CXXC1 | 10346 | 0.150991 | 0.76 | 1.8e-02 | Click! |
chr18_47813563_47813872 | CXXC1 | 223 | 0.915004 | 0.75 | 2.1e-02 | Click! |
chr18_47812907_47813058 | CXXC1 | 958 | 0.493932 | 0.58 | 9.9e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr16_46723855_46724148 | 3.34 |
ORC6 |
origin recognition complex, subunit 6 |
392 |
0.71 |
chr2_172966798_172967017 | 2.97 |
DLX2 |
distal-less homeobox 2 |
721 |
0.7 |
chr18_55469691_55470011 | 2.63 |
ATP8B1 |
ATPase, aminophospholipid transporter, class I, type 8B, member 1 |
476 |
0.85 |
chr6_41341429_41341783 | 2.62 |
ENSG00000238867 |
. |
18419 |
0.17 |
chr19_11159205_11159728 | 2.53 |
SMARCA4 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
10045 |
0.14 |
chrX_128657158_128657391 | 2.34 |
SMARCA1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 |
186 |
0.96 |
chr12_59990043_59990194 | 2.29 |
SLC16A7 |
solute carrier family 16 (monocarboxylate transporter), member 7 |
175 |
0.95 |
chr15_71055053_71055278 | 2.26 |
UACA |
uveal autoantigen with coiled-coil domains and ankyrin repeats |
604 |
0.76 |
chr8_70981617_70981839 | 2.25 |
PRDM14 |
PR domain containing 14 |
1834 |
0.37 |
chr9_139743544_139743695 | 2.25 |
PHPT1 |
phosphohistidine phosphatase 1 |
73 |
0.91 |
chr5_98105577_98106046 | 2.22 |
RGMB |
repulsive guidance molecule family member b |
812 |
0.65 |
chr22_20229537_20229756 | 2.19 |
RTN4R |
reticulon 4 receptor |
1561 |
0.29 |
chr10_121262368_121262551 | 2.18 |
RGS10 |
regulator of G-protein signaling 10 |
24530 |
0.21 |
chr14_77227890_77228041 | 2.18 |
VASH1 |
vasohibin 1 |
567 |
0.76 |
chr16_89183297_89183612 | 2.17 |
CTD-2555A7.3 |
|
1767 |
0.3 |
chr8_42698780_42698964 | 2.13 |
THAP1 |
THAP domain containing, apoptosis associated protein 1 |
404 |
0.82 |
chr9_4299240_4299554 | 2.13 |
RP11-358M14.2 |
|
7 |
0.91 |
chr17_48277202_48277353 | 2.12 |
COL1A1 |
collagen, type I, alpha 1 |
275 |
0.85 |
chr7_37382444_37382741 | 2.11 |
ELMO1 |
engulfment and cell motility 1 |
191 |
0.95 |
chr14_91864420_91864751 | 2.09 |
CCDC88C |
coiled-coil domain containing 88C |
19105 |
0.21 |
chr7_150076742_150076893 | 2.07 |
ZNF775 |
zinc finger protein 775 |
393 |
0.75 |
chr16_4400670_4400971 | 2.03 |
PAM16 |
presequence translocase-associated motor 16 homolog (S. cerevisiae) |
446 |
0.73 |
chr5_176799321_176799505 | 2.02 |
RGS14 |
regulator of G-protein signaling 14 |
5469 |
0.1 |
chr3_194354391_194354771 | 2.02 |
TMEM44 |
transmembrane protein 44 |
163 |
0.88 |
chr7_2395079_2395316 | 2.02 |
EIF3B |
eukaryotic translation initiation factor 3, subunit B |
680 |
0.58 |
chr19_49972092_49972277 | 1.97 |
FLT3LG |
fms-related tyrosine kinase 3 ligand |
5301 |
0.06 |
chr4_154710777_154711014 | 1.96 |
SFRP2 |
secreted frizzled-related protein 2 |
623 |
0.75 |
chr8_101170505_101170656 | 1.94 |
SPAG1 |
sperm associated antigen 1 |
17 |
0.9 |
chr1_51435334_51435485 | 1.94 |
CDKN2C |
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
207 |
0.95 |
chr16_30197806_30198032 | 1.92 |
RP11-455F5.5 |
|
1641 |
0.16 |
chr6_147524433_147524709 | 1.90 |
STXBP5-AS1 |
STXBP5 antisense RNA 1 |
968 |
0.43 |
chr9_116038140_116038291 | 1.90 |
PRPF4 |
pre-mRNA processing factor 4 |
293 |
0.53 |
chr9_127177334_127177485 | 1.89 |
PSMB7 |
proteasome (prosome, macropain) subunit, beta type, 7 |
309 |
0.9 |
chr9_127265973_127266250 | 1.89 |
NR5A1 |
nuclear receptor subfamily 5, group A, member 1 |
2846 |
0.29 |
chr12_133135006_133135416 | 1.88 |
P2RX2 |
purinergic receptor P2X, ligand-gated ion channel, 2 |
60155 |
0.1 |
chr7_5464158_5464311 | 1.86 |
TNRC18 |
trinucleotide repeat containing 18 |
811 |
0.53 |
chr4_157891688_157891895 | 1.86 |
PDGFC |
platelet derived growth factor C |
264 |
0.93 |
chr8_42753155_42753538 | 1.86 |
RNF170 |
ring finger protein 170 |
913 |
0.37 |
chr3_129034539_129034690 | 1.86 |
H1FX-AS1 |
H1FX antisense RNA 1 |
251 |
0.71 |
chr10_14920158_14920449 | 1.85 |
SUV39H2 |
suppressor of variegation 3-9 homolog 2 (Drosophila) |
544 |
0.76 |
chr2_227663405_227663664 | 1.85 |
IRS1 |
insulin receptor substrate 1 |
941 |
0.59 |
chr20_56056443_56056654 | 1.82 |
CTCFL |
CCCTC-binding factor (zinc finger protein)-like |
42765 |
0.14 |
chr19_42145386_42145612 | 1.80 |
CEACAM4 |
carcinoembryonic antigen-related cell adhesion molecule 4 |
12057 |
0.14 |
chr8_144655209_144655539 | 1.80 |
MROH6 |
maestro heat-like repeat family member 6 |
233 |
0.51 |
chr3_14219692_14219843 | 1.79 |
LSM3 |
LSM3 homolog, U6 small nuclear RNA associated (S. cerevisiae) |
91 |
0.77 |
chr6_144164635_144164786 | 1.78 |
LTV1 |
LTV1 homolog (S. cerevisiae) |
229 |
0.95 |
chrX_38663515_38663666 | 1.77 |
MID1IP1-AS1 |
MID1IP1 antisense RNA 1 |
454 |
0.58 |
chr1_236306715_236306919 | 1.77 |
GPR137B |
G protein-coupled receptor 137B |
749 |
0.72 |
chr11_118889854_118890205 | 1.76 |
ENSG00000266398 |
. |
375 |
0.42 |
chr3_196015117_196015307 | 1.75 |
PCYT1A |
phosphate cytidylyltransferase 1, choline, alpha |
384 |
0.78 |
chr11_121385454_121385845 | 1.75 |
SORL1 |
sortilin-related receptor, L(DLR class) A repeats containing |
51785 |
0.16 |
chr7_95915179_95915330 | 1.74 |
ENSG00000220987 |
. |
20918 |
0.16 |
chr19_9648810_9649108 | 1.73 |
ZNF426 |
zinc finger protein 426 |
105 |
0.96 |
chr9_130922173_130922339 | 1.72 |
C9orf16 |
chromosome 9 open reading frame 16 |
283 |
0.81 |
chr17_38737904_38738640 | 1.72 |
CCR7 |
chemokine (C-C motif) receptor 7 |
16548 |
0.15 |
chr16_4898192_4898343 | 1.71 |
UBN1 |
ubinuclein 1 |
114 |
0.91 |
chr1_147834380_147834531 | 1.71 |
ENSG00000207340 |
. |
210 |
0.91 |
chr12_69201334_69201485 | 1.71 |
MDM2 |
MDM2 oncogene, E3 ubiquitin protein ligase |
547 |
0.71 |
chr22_31503016_31503202 | 1.71 |
SELM |
Selenoprotein M |
445 |
0.71 |
chr1_183440737_183440894 | 1.70 |
SMG7 |
SMG7 nonsense mediated mRNA decay factor |
691 |
0.73 |
chr1_860079_860301 | 1.70 |
SAMD11 |
sterile alpha motif domain containing 11 |
70 |
0.95 |
chr11_58265789_58265973 | 1.70 |
OR5B21 |
olfactory receptor, family 5, subfamily B, member 21 |
9697 |
0.18 |
chr22_39052385_39052581 | 1.69 |
FAM227A |
family with sequence similarity 227, member A |
151 |
0.49 |
chr5_76926266_76926462 | 1.69 |
OTP |
orthopedia homeobox |
9149 |
0.23 |
chr22_40296066_40296492 | 1.69 |
GRAP2 |
GRB2-related adaptor protein 2 |
807 |
0.6 |
chr21_43611873_43612084 | 1.69 |
ABCG1 |
ATP-binding cassette, sub-family G (WHITE), member 1 |
7821 |
0.2 |
chrX_150067895_150068115 | 1.69 |
CD99L2 |
CD99 molecule-like 2 |
716 |
0.66 |
chr1_40505800_40505951 | 1.68 |
CAP1 |
CAP, adenylate cyclase-associated protein 1 (yeast) |
30 |
0.98 |
chr2_106886194_106886539 | 1.68 |
UXS1 |
UDP-glucuronate decarboxylase 1 |
75571 |
0.1 |
chr9_138999867_139000258 | 1.68 |
C9orf69 |
chromosome 9 open reading frame 69 |
10058 |
0.19 |
chr2_233470885_233471036 | 1.66 |
EFHD1 |
EF-hand domain family, member D1 |
193 |
0.91 |
chr7_1514329_1514480 | 1.66 |
INTS1 |
integrator complex subunit 1 |
1618 |
0.31 |
chr6_159462384_159462599 | 1.66 |
TAGAP |
T-cell activation RhoGTPase activating protein |
3559 |
0.24 |
chr19_33862847_33863015 | 1.65 |
CEBPG |
CCAAT/enhancer binding protein (C/EBP), gamma |
1305 |
0.46 |
chr2_20646793_20647016 | 1.65 |
RHOB |
ras homolog family member B |
69 |
0.98 |
chr22_50752388_50752886 | 1.64 |
XX-C283C717.1 |
|
423 |
0.69 |
chr1_39024766_39024977 | 1.64 |
ENSG00000200796 |
. |
162540 |
0.04 |
chr19_30167811_30167962 | 1.64 |
PLEKHF1 |
pleckstrin homology domain containing, family F (with FYVE domain) member 1 |
10105 |
0.22 |
chrX_117852519_117852869 | 1.64 |
IL13RA1 |
interleukin 13 receptor, alpha 1 |
8841 |
0.23 |
chr12_783470_783778 | 1.64 |
NINJ2 |
ninjurin 2 |
10679 |
0.18 |
chr15_52860751_52860902 | 1.64 |
ARPP19 |
cAMP-regulated phosphoprotein, 19kDa |
203 |
0.94 |
chr5_98106086_98106237 | 1.63 |
RGMB |
repulsive guidance molecule family member b |
1162 |
0.5 |
chr6_74019532_74019844 | 1.62 |
KHDC1 |
KH homology domain containing 1 |
250 |
0.88 |
chrX_152864985_152865281 | 1.62 |
RP11-66N11.8 |
|
306 |
0.53 |
chr7_155078951_155079478 | 1.61 |
INSIG1 |
insulin induced gene 1 |
10272 |
0.22 |
chr10_77161826_77162020 | 1.61 |
ZNF503 |
zinc finger protein 503 |
259 |
0.78 |
chr11_94502182_94502474 | 1.61 |
AMOTL1 |
angiomotin like 1 |
791 |
0.7 |
chr20_61570084_61570247 | 1.61 |
GID8 |
GID complex subunit 8 |
694 |
0.45 |
chr15_101817244_101817395 | 1.60 |
VIMP |
VCP-interacting membrane protein |
173 |
0.93 |
chr17_2700622_2700773 | 1.60 |
RAP1GAP2 |
RAP1 GTPase activating protein 2 |
921 |
0.56 |
chr13_115001270_115001491 | 1.60 |
CDC16 |
cell division cycle 16 |
824 |
0.59 |
chr1_8022017_8022305 | 1.58 |
PARK7 |
parkinson protein 7 |
132 |
0.96 |
chr14_105541201_105541383 | 1.58 |
GPR132 |
G protein-coupled receptor 132 |
9510 |
0.19 |
chr19_33072637_33072875 | 1.58 |
PDCD5 |
programmed cell death 5 |
324 |
0.88 |
chr2_234474872_234475097 | 1.58 |
USP40 |
ubiquitin specific peptidase 40 |
396 |
0.86 |
chr17_35292353_35292544 | 1.58 |
RP11-445F12.1 |
|
1473 |
0.26 |
chr17_42634506_42634717 | 1.58 |
FZD2 |
frizzled family receptor 2 |
314 |
0.89 |
chr2_36584288_36584791 | 1.57 |
CRIM1 |
cysteine rich transmembrane BMP regulator 1 (chordin-like) |
925 |
0.73 |
chr2_136872566_136873100 | 1.57 |
CXCR4 |
chemokine (C-X-C motif) receptor 4 |
980 |
0.68 |
chr9_3525131_3525338 | 1.57 |
RFX3 |
regulatory factor X, 3 (influences HLA class II expression) |
749 |
0.77 |
chr15_89671557_89671708 | 1.57 |
ENSG00000239151 |
. |
7622 |
0.19 |
chr8_144714810_144714985 | 1.56 |
RP11-661A12.12 |
|
1029 |
0.27 |
chr19_37957563_37957802 | 1.56 |
ZNF569 |
zinc finger protein 569 |
428 |
0.68 |
chr8_95732220_95732371 | 1.56 |
DPY19L4 |
dpy-19-like 4 (C. elegans) |
167 |
0.95 |
chr3_53915683_53915834 | 1.56 |
ACTR8 |
ARP8 actin-related protein 8 homolog (yeast) |
93 |
0.87 |
chr10_134365433_134366156 | 1.56 |
INPP5A |
inositol polyphosphate-5-phosphatase, 40kDa |
14151 |
0.21 |
chr3_15140082_15140257 | 1.56 |
ZFYVE20 |
zinc finger, FYVE domain containing 20 |
474 |
0.8 |
chr6_42011445_42011596 | 1.56 |
CCND3 |
cyclin D3 |
4904 |
0.17 |
chr10_111970132_111970295 | 1.55 |
MXI1 |
MAX interactor 1, dimerization protein |
224 |
0.93 |
chr1_117602981_117603207 | 1.55 |
TTF2 |
transcription termination factor, RNA polymerase II |
169 |
0.9 |
chr4_7657217_7657368 | 1.55 |
SORCS2 |
sortilin-related VPS10 domain containing receptor 2 |
78715 |
0.1 |
chr3_16554171_16554353 | 1.55 |
RFTN1 |
raftlin, lipid raft linker 1 |
149 |
0.97 |
chr7_36430138_36430483 | 1.54 |
ANLN |
anillin, actin binding protein |
466 |
0.53 |
chr15_31652772_31653037 | 1.54 |
KLF13 |
Kruppel-like factor 13 |
5453 |
0.33 |
chr17_7236874_7237266 | 1.54 |
ACAP1 |
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
2778 |
0.09 |
chr1_121138439_121138636 | 1.54 |
FCGR1B |
Fc fragment of IgG, high affinity Ib, receptor (CD64) |
202600 |
0.02 |
chr15_33011128_33011364 | 1.53 |
GREM1 |
gremlin 1, DAN family BMP antagonist |
1041 |
0.55 |
chr2_10443443_10443594 | 1.53 |
HPCAL1 |
hippocalcin-like 1 |
308 |
0.89 |
chr9_94185163_94185463 | 1.53 |
NFIL3 |
nuclear factor, interleukin 3 regulated |
831 |
0.74 |
chr19_2476945_2477096 | 1.53 |
GADD45B |
growth arrest and DNA-damage-inducible, beta |
666 |
0.63 |
chr8_21905289_21905440 | 1.53 |
DMTN |
dematin actin binding protein |
1142 |
0.35 |
chr22_50056911_50057062 | 1.53 |
C22orf34 |
chromosome 22 open reading frame 34 |
5796 |
0.22 |
chr5_138677761_138677912 | 1.52 |
PAIP2 |
poly(A) binding protein interacting protein 2 |
269 |
0.84 |
chr1_8013745_8014051 | 1.52 |
PARK7 |
parkinson protein 7 |
453 |
0.81 |
chr7_17338891_17339212 | 1.52 |
AC003075.4 |
|
70 |
0.94 |
chr18_32621847_32622144 | 1.51 |
MAPRE2 |
microtubule-associated protein, RP/EB family, member 2 |
381 |
0.92 |
chr1_95392133_95392325 | 1.51 |
CNN3 |
calponin 3, acidic |
409 |
0.71 |
chrX_62974152_62974365 | 1.51 |
ARHGEF9 |
Cdc42 guanine nucleotide exchange factor (GEF) 9 |
730 |
0.74 |
chr20_49575914_49576065 | 1.50 |
MOCS3 |
molybdenum cofactor synthesis 3 |
626 |
0.49 |
chr15_33009764_33009965 | 1.50 |
GREM1 |
gremlin 1, DAN family BMP antagonist |
311 |
0.9 |
chr2_39663690_39663854 | 1.50 |
AC007246.3 |
|
6 |
0.89 |
chr20_2633878_2634215 | 1.50 |
ENSG00000221062 |
. |
623 |
0.29 |
chr11_67057492_67057673 | 1.49 |
ANKRD13D |
ankyrin repeat domain 13 family, member D |
709 |
0.54 |
chr16_71880385_71880588 | 1.49 |
IST1 |
increased sodium tolerance 1 homolog (yeast) |
587 |
0.41 |
chr14_91876524_91876913 | 1.49 |
CCDC88C |
coiled-coil domain containing 88C |
6972 |
0.25 |
chr2_112252171_112252572 | 1.49 |
ENSG00000266139 |
. |
173703 |
0.03 |
chr5_175123108_175123334 | 1.48 |
ENSG00000200648 |
. |
7680 |
0.21 |
chr17_45331360_45331511 | 1.48 |
ITGB3 |
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) |
172 |
0.93 |
chr5_169739003_169739460 | 1.48 |
LCP2 |
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
14000 |
0.2 |
chr14_65510786_65511085 | 1.48 |
ENSG00000266531 |
. |
471 |
0.75 |
chr19_46144084_46144235 | 1.48 |
EML2 |
echinoderm microtubule associated protein like 2 |
770 |
0.3 |
chr20_3140580_3140731 | 1.48 |
FASTKD5 |
FAST kinase domains 5 |
112 |
0.52 |
chr5_171602606_171602757 | 1.47 |
STK10 |
serine/threonine kinase 10 |
12709 |
0.19 |
chr16_31488502_31488862 | 1.47 |
TGFB1I1 |
transforming growth factor beta 1 induced transcript 1 |
3935 |
0.1 |
chr15_72409182_72409644 | 1.47 |
SENP8 |
SUMO/sentrin specific peptidase family member 8 |
167 |
0.86 |
chr21_47742979_47743225 | 1.47 |
C21orf58 |
chromosome 21 open reading frame 58 |
669 |
0.47 |
chr13_103451004_103451240 | 1.47 |
KDELC1 |
KDEL (Lys-Asp-Glu-Leu) containing 1 |
235 |
0.52 |
chr3_71632244_71632475 | 1.47 |
FOXP1 |
forkhead box P1 |
545 |
0.79 |
chr9_129427654_129427805 | 1.46 |
RP11-123K19.2 |
|
24694 |
0.16 |
chr17_72426445_72426696 | 1.46 |
GPRC5C |
G protein-coupled receptor, family C, group 5, member C |
482 |
0.74 |
chrX_133682335_133682486 | 1.46 |
ENSG00000223749 |
. |
1669 |
0.22 |
chr11_18126985_18127156 | 1.46 |
SAAL1 |
serum amyloid A-like 1 |
496 |
0.73 |
chr19_1080812_1081063 | 1.46 |
HMHA1 |
histocompatibility (minor) HA-1 |
3495 |
0.12 |
chr11_2950249_2950458 | 1.45 |
PHLDA2 |
pleckstrin homology-like domain, family A, member 2 |
332 |
0.82 |
chr7_157644645_157644994 | 1.45 |
AC011899.9 |
|
2402 |
0.35 |
chr8_20161069_20161242 | 1.45 |
LZTS1 |
leucine zipper, putative tumor suppressor 1 |
319 |
0.91 |
chr3_167812788_167813088 | 1.45 |
GOLIM4 |
golgi integral membrane protein 4 |
194 |
0.97 |
chr5_17216432_17216695 | 1.45 |
AC091878.1 |
|
593 |
0.61 |
chr17_48277363_48277626 | 1.44 |
COL1A1 |
collagen, type I, alpha 1 |
58 |
0.96 |
chr13_111267845_111267996 | 1.44 |
CARKD |
carbohydrate kinase domain containing |
2 |
0.98 |
chr11_82996564_82996715 | 1.44 |
CCDC90B |
coiled-coil domain containing 90B |
382 |
0.59 |
chr2_109745068_109745415 | 1.44 |
SH3RF3 |
SH3 domain containing ring finger 3 |
563 |
0.81 |
chr1_230286883_230287034 | 1.43 |
GALNT2 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2) |
83940 |
0.09 |
chr11_6947826_6947982 | 1.43 |
ZNF215 |
zinc finger protein 215 |
151 |
0.94 |
chr1_156469221_156469372 | 1.43 |
MEF2D |
myocyte enhancer factor 2D |
1233 |
0.34 |
chrX_136135361_136135512 | 1.43 |
GPR101 |
G protein-coupled receptor 101 |
21603 |
0.23 |
chr7_112031669_112031820 | 1.42 |
AC004112.4 |
|
17934 |
0.19 |
chr22_41597347_41597566 | 1.42 |
L3MBTL2 |
l(3)mbt-like 2 (Drosophila) |
3753 |
0.13 |
chrX_149530829_149530999 | 1.42 |
MAMLD1 |
mastermind-like domain containing 1 |
637 |
0.82 |
chr5_92916417_92916950 | 1.42 |
ENSG00000237187 |
. |
30 |
0.98 |
chr2_27530014_27530299 | 1.42 |
UCN |
urocortin |
1157 |
0.27 |
chr9_34989021_34989239 | 1.41 |
DNAJB5 |
DnaJ (Hsp40) homolog, subfamily B, member 5 |
508 |
0.73 |
chr10_134045897_134046048 | 1.41 |
DPYSL4 |
dihydropyrimidinase-like 4 |
39708 |
0.15 |
chr11_101981630_101981828 | 1.41 |
YAP1 |
Yes-associated protein 1 |
149 |
0.95 |
chr10_71332183_71332596 | 1.40 |
NEUROG3 |
neurogenin 3 |
605 |
0.72 |
chr18_2656528_2656679 | 1.40 |
SMCHD1 |
structural maintenance of chromosomes flexible hinge domain containing 1 |
717 |
0.63 |
chr1_86046764_86046989 | 1.40 |
CYR61 |
cysteine-rich, angiogenic inducer, 61 |
432 |
0.82 |
chr22_36805840_36806022 | 1.40 |
MYH9 |
myosin, heavy chain 9, non-muscle |
21868 |
0.14 |
chr9_34377373_34377600 | 1.40 |
KIAA1161 |
KIAA1161 |
635 |
0.6 |
chr13_75900480_75900669 | 1.39 |
TBC1D4 |
TBC1 domain family, member 4 |
15093 |
0.24 |
chr2_98262920_98263071 | 1.39 |
COX5B |
cytochrome c oxidase subunit Vb |
492 |
0.75 |
chr1_156085465_156085736 | 1.38 |
LMNA |
lamin A/C |
1087 |
0.35 |
chr22_39268790_39269060 | 1.38 |
CBX6 |
chromobox homolog 6 |
606 |
0.68 |
chr17_79478195_79478346 | 1.38 |
ENSG00000266077 |
. |
135 |
0.9 |
chr4_105413109_105413318 | 1.38 |
CXXC4 |
CXXC finger protein 4 |
746 |
0.44 |
chr12_110840817_110840987 | 1.38 |
ANAPC7 |
anaphase promoting complex subunit 7 |
633 |
0.68 |
chr2_68959035_68959331 | 1.38 |
ARHGAP25 |
Rho GTPase activating protein 25 |
2730 |
0.35 |
chr19_6775270_6775712 | 1.38 |
VAV1 |
vav 1 guanine nucleotide exchange factor |
2522 |
0.19 |
chr9_130375577_130375745 | 1.38 |
STXBP1 |
syntaxin binding protein 1 |
1093 |
0.47 |
chr11_65790274_65790439 | 1.38 |
CATSPER1 |
cation channel, sperm associated 1 |
3632 |
0.11 |
chr10_91011035_91011451 | 1.38 |
LIPA |
lipase A, lysosomal acid, cholesterol esterase |
417 |
0.8 |
chr16_53089210_53089373 | 1.38 |
CHD9 |
chromodomain helicase DNA binding protein 9 |
346 |
0.89 |
chr7_35226374_35226652 | 1.38 |
DPY19L2P1 |
DPY19L2 pseudogene 1 |
579 |
0.84 |
chr20_50807513_50807796 | 1.37 |
ZFP64 |
ZFP64 zinc finger protein |
582 |
0.86 |
chr9_351038_351189 | 1.37 |
DOCK8 |
dedicator of cytokinesis 8 |
15116 |
0.22 |
chr19_2476220_2476404 | 1.37 |
GADD45B |
growth arrest and DNA-damage-inducible, beta |
42 |
0.97 |
chr21_40746210_40746382 | 1.37 |
WRB |
tryptophan rich basic protein |
5874 |
0.14 |
chr3_196668934_196669213 | 1.37 |
NCBP2 |
nuclear cap binding protein subunit 2, 20kDa |
175 |
0.91 |
chr1_32110855_32111015 | 1.37 |
RP11-73M7.6 |
|
12 |
0.84 |
chr11_1557865_1558016 | 1.36 |
DUSP8 |
dual specificity phosphatase 8 |
29226 |
0.11 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 8.5 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
1.3 | 3.9 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) regulation of mesoderm development(GO:2000380) |
1.3 | 2.6 | GO:0030223 | neutrophil differentiation(GO:0030223) |
1.3 | 5.1 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
1.2 | 3.7 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
1.2 | 3.6 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
1.2 | 1.2 | GO:0048541 | Peyer's patch development(GO:0048541) |
1.2 | 4.7 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
1.1 | 3.3 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
1.1 | 1.1 | GO:0002326 | B cell lineage commitment(GO:0002326) |
1.1 | 7.5 | GO:0032367 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
1.0 | 3.1 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
1.0 | 2.1 | GO:0043374 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
1.0 | 3.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
1.0 | 1.0 | GO:0045661 | regulation of myoblast differentiation(GO:0045661) positive regulation of myoblast differentiation(GO:0045663) |
1.0 | 4.0 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
1.0 | 3.9 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
1.0 | 2.9 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.0 | 4.9 | GO:0002664 | T cell tolerance induction(GO:0002517) regulation of T cell tolerance induction(GO:0002664) positive regulation of T cell tolerance induction(GO:0002666) |
1.0 | 1.9 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
1.0 | 2.9 | GO:0000255 | allantoin metabolic process(GO:0000255) creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.9 | 0.9 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.9 | 2.8 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.9 | 4.6 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.9 | 6.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.9 | 2.7 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.9 | 0.9 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.9 | 4.5 | GO:0046645 | regulation of gamma-delta T cell activation(GO:0046643) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.9 | 1.8 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.9 | 2.6 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.9 | 3.5 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.9 | 3.5 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.9 | 0.9 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
0.9 | 1.7 | GO:0002643 | regulation of tolerance induction(GO:0002643) positive regulation of tolerance induction(GO:0002645) |
0.9 | 0.9 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.9 | 0.9 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.8 | 4.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.8 | 2.5 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.8 | 5.0 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.8 | 2.5 | GO:0046137 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.8 | 0.8 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.8 | 2.4 | GO:0043320 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.8 | 3.2 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.8 | 3.2 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.8 | 2.3 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
0.8 | 3.1 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.8 | 2.3 | GO:0046881 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.8 | 1.5 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.7 | 2.2 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.7 | 0.7 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.7 | 2.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.7 | 3.6 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.7 | 0.7 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.7 | 1.4 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.7 | 2.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.7 | 0.7 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.7 | 3.5 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.7 | 4.9 | GO:0007172 | signal complex assembly(GO:0007172) |
0.7 | 1.4 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.7 | 2.8 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.7 | 0.7 | GO:0043393 | regulation of protein binding(GO:0043393) |
0.7 | 1.4 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.7 | 3.4 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.7 | 1.4 | GO:0060596 | mammary placode formation(GO:0060596) |
0.7 | 1.4 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.7 | 1.3 | GO:1903429 | regulation of neuron maturation(GO:0014041) regulation of cell maturation(GO:1903429) |
0.7 | 1.3 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.7 | 1.3 | GO:0060242 | contact inhibition(GO:0060242) |
0.7 | 4.0 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
0.7 | 2.6 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.7 | 2.0 | GO:0031558 | obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
0.6 | 1.9 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.6 | 5.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.6 | 1.9 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.6 | 5.1 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.6 | 2.6 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.6 | 0.6 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.6 | 1.9 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.6 | 3.2 | GO:0001553 | luteinization(GO:0001553) |
0.6 | 1.3 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.6 | 1.9 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.6 | 0.6 | GO:0010193 | response to ozone(GO:0010193) |
0.6 | 2.4 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.6 | 1.2 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.6 | 1.8 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.6 | 1.2 | GO:0090116 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.6 | 0.6 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.6 | 1.2 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.6 | 2.4 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.6 | 3.0 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.6 | 1.8 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.6 | 3.0 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.6 | 1.8 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.6 | 7.1 | GO:0031648 | protein destabilization(GO:0031648) |
0.6 | 1.8 | GO:0060430 | lung saccule development(GO:0060430) Type II pneumocyte differentiation(GO:0060510) |
0.6 | 1.8 | GO:1901339 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.6 | 3.5 | GO:0006991 | response to sterol depletion(GO:0006991) |
0.6 | 1.8 | GO:0045995 | regulation of embryonic development(GO:0045995) |
0.6 | 0.6 | GO:0061299 | retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.6 | 3.5 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.6 | 1.7 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.6 | 0.6 | GO:0060157 | urinary bladder development(GO:0060157) |
0.6 | 1.7 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.6 | 0.6 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.6 | 2.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.6 | 4.0 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.6 | 4.0 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.6 | 2.8 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.6 | 0.6 | GO:0002507 | tolerance induction(GO:0002507) |
0.6 | 1.7 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.6 | 1.7 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.6 | 2.8 | GO:0045683 | negative regulation of epidermis development(GO:0045683) |
0.6 | 3.4 | GO:0061647 | histone H3-K9 methylation(GO:0051567) histone H3-K9 modification(GO:0061647) |
0.6 | 2.2 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.6 | 1.7 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.6 | 0.6 | GO:0021779 | oligodendrocyte cell fate commitment(GO:0021779) |
0.6 | 1.7 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.6 | 2.8 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.6 | 3.9 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.5 | 5.5 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.5 | 0.5 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.5 | 5.5 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.5 | 0.5 | GO:0072203 | cell proliferation involved in metanephros development(GO:0072203) |
0.5 | 0.5 | GO:0090002 | establishment of protein localization to plasma membrane(GO:0090002) |
0.5 | 2.7 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.5 | 0.5 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.5 | 2.2 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.5 | 1.6 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.5 | 2.2 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.5 | 5.9 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.5 | 1.1 | GO:0001705 | ectoderm formation(GO:0001705) |
0.5 | 2.1 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of reactive oxygen species biosynthetic process(GO:1903427) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.5 | 3.2 | GO:0061384 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.5 | 4.2 | GO:0010324 | phagocytosis, engulfment(GO:0006911) membrane invagination(GO:0010324) |
0.5 | 2.6 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.5 | 1.6 | GO:0072133 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.5 | 0.5 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.5 | 1.6 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.5 | 2.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.5 | 1.6 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.5 | 1.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.5 | 1.6 | GO:0060438 | trachea development(GO:0060438) |
0.5 | 1.0 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.5 | 1.6 | GO:0006562 | proline catabolic process(GO:0006562) |
0.5 | 2.1 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.5 | 1.0 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.5 | 1.5 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.5 | 0.5 | GO:0060079 | excitatory postsynaptic potential(GO:0060079) |
0.5 | 2.0 | GO:0008218 | bioluminescence(GO:0008218) |
0.5 | 1.5 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.5 | 2.5 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.5 | 0.5 | GO:0051665 | membrane raft localization(GO:0051665) |
0.5 | 5.6 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.5 | 2.0 | GO:1903313 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.5 | 1.0 | GO:0046931 | pore complex assembly(GO:0046931) |
0.5 | 2.0 | GO:1902808 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.5 | 1.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.5 | 0.5 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.5 | 1.0 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.5 | 2.0 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.5 | 0.5 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.5 | 0.5 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.5 | 0.5 | GO:0051014 | actin filament severing(GO:0051014) |
0.5 | 1.5 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.5 | 1.5 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.5 | 2.5 | GO:0007346 | regulation of mitotic cell cycle(GO:0007346) |
0.5 | 1.0 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.5 | 0.5 | GO:0035329 | hippo signaling(GO:0035329) |
0.5 | 1.0 | GO:0032661 | interleukin-18 production(GO:0032621) regulation of interleukin-18 production(GO:0032661) |
0.5 | 0.5 | GO:0001893 | maternal placenta development(GO:0001893) |
0.5 | 4.9 | GO:0051322 | anaphase(GO:0051322) |
0.5 | 3.4 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.5 | 1.0 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.5 | 4.9 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.5 | 5.8 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.5 | 2.4 | GO:0001878 | response to yeast(GO:0001878) |
0.5 | 1.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.5 | 1.9 | GO:0032986 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.5 | 0.5 | GO:0051225 | spindle assembly(GO:0051225) |
0.5 | 1.4 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.5 | 0.5 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.5 | 0.5 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.5 | 1.0 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.5 | 1.0 | GO:0042345 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.5 | 0.5 | GO:0052251 | induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) |
0.5 | 1.4 | GO:0017085 | response to insecticide(GO:0017085) |
0.5 | 0.9 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.5 | 5.7 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.5 | 0.5 | GO:2000644 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) regulation of receptor catabolic process(GO:2000644) |
0.5 | 0.9 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.5 | 0.5 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.5 | 0.9 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.5 | 1.9 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.5 | 0.5 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.5 | 2.8 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.5 | 0.5 | GO:0048011 | neurotrophin signaling pathway(GO:0038179) neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.5 | 1.4 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.5 | 1.9 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.5 | 0.9 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.5 | 1.4 | GO:0015705 | iodide transport(GO:0015705) |
0.5 | 4.6 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.5 | 0.9 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.5 | 2.3 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.5 | 1.8 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.5 | 1.4 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.5 | 0.5 | GO:0071436 | sodium ion export(GO:0071436) |
0.5 | 0.5 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.5 | 0.9 | GO:0046398 | UDP-glucuronate biosynthetic process(GO:0006065) UDP-glucuronate metabolic process(GO:0046398) |
0.5 | 1.8 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.5 | 1.4 | GO:0097502 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
0.5 | 0.9 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.5 | 4.6 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.5 | 0.5 | GO:0030177 | positive regulation of Wnt signaling pathway(GO:0030177) |
0.5 | 0.9 | GO:0030282 | bone mineralization(GO:0030282) |
0.5 | 0.5 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.5 | 0.5 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.5 | 0.5 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.5 | 0.5 | GO:0046823 | negative regulation of nucleocytoplasmic transport(GO:0046823) |
0.5 | 2.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.4 | 3.6 | GO:0006491 | N-glycan processing(GO:0006491) |
0.4 | 7.2 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.4 | 2.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.4 | 5.3 | GO:0006385 | transcription elongation from RNA polymerase III promoter(GO:0006385) termination of RNA polymerase III transcription(GO:0006386) |
0.4 | 10.7 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.4 | 0.4 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.4 | 1.3 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.4 | 1.3 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.4 | 9.7 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.4 | 0.9 | GO:0032730 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.4 | 1.3 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.4 | 1.7 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.4 | 2.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.4 | 3.0 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.4 | 1.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.4 | 0.4 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.4 | 0.4 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.4 | 1.7 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.4 | 0.9 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002823) |
0.4 | 0.9 | GO:0031935 | regulation of chromatin silencing(GO:0031935) |
0.4 | 1.3 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.4 | 2.6 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.4 | 0.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.4 | 2.1 | GO:0032202 | telomere assembly(GO:0032202) |
0.4 | 0.8 | GO:0006839 | mitochondrial transport(GO:0006839) |
0.4 | 1.3 | GO:0032874 | positive regulation of stress-activated MAPK cascade(GO:0032874) positive regulation of stress-activated protein kinase signaling cascade(GO:0070304) |
0.4 | 0.4 | GO:0003159 | morphogenesis of an endothelium(GO:0003159) |
0.4 | 0.8 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.4 | 0.8 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.4 | 1.3 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.4 | 3.4 | GO:0001706 | endoderm formation(GO:0001706) |
0.4 | 1.3 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.4 | 0.8 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.4 | 0.4 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.4 | 0.4 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.4 | 1.7 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) negative regulation of B cell apoptotic process(GO:0002903) |
0.4 | 1.3 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.4 | 1.3 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.4 | 0.8 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.4 | 2.9 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.4 | 0.8 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.4 | 1.2 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.4 | 0.8 | GO:0046337 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.4 | 0.4 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.4 | 0.4 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) |
0.4 | 3.7 | GO:0032456 | endocytic recycling(GO:0032456) |
0.4 | 4.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.4 | 2.9 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.4 | 1.2 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.4 | 0.4 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.4 | 12.7 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) negative regulation of proteasomal protein catabolic process(GO:1901799) |
0.4 | 0.4 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.4 | 3.3 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.4 | 1.2 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.4 | 2.8 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.4 | 0.4 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.4 | 3.2 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.4 | 2.0 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.4 | 2.4 | GO:0044349 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.4 | 0.4 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.4 | 2.0 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.4 | 0.8 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.4 | 2.8 | GO:1904031 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.4 | 3.2 | GO:0072599 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.4 | 1.2 | GO:0019054 | modulation by virus of host process(GO:0019054) modulation by symbiont of host cellular process(GO:0044068) |
0.4 | 1.2 | GO:0048664 | neuron fate determination(GO:0048664) |
0.4 | 0.8 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.4 | 1.6 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.4 | 2.0 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.4 | 0.8 | GO:0032392 | DNA geometric change(GO:0032392) |
0.4 | 2.4 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.4 | 0.8 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.4 | 0.4 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.4 | 0.8 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.4 | 0.4 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.4 | 0.8 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.4 | 0.4 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.4 | 0.4 | GO:0072201 | cloaca development(GO:0035844) cloacal septation(GO:0060197) negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.4 | 1.6 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.4 | 3.1 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.4 | 1.2 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.4 | 2.3 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.4 | 1.2 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.4 | 1.2 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.4 | 0.4 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.4 | 2.3 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.4 | 2.7 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.4 | 0.8 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.4 | 0.4 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.4 | 1.1 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.4 | 1.1 | GO:0006828 | manganese ion transport(GO:0006828) |
0.4 | 1.1 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.4 | 0.8 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.4 | 1.5 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.4 | 1.9 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.4 | 1.9 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.4 | 0.4 | GO:0042026 | protein refolding(GO:0042026) |
0.4 | 2.6 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.4 | 1.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.4 | 0.4 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.4 | 2.2 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.4 | 0.7 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.4 | 1.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.4 | 3.0 | GO:0045843 | negative regulation of striated muscle tissue development(GO:0045843) negative regulation of muscle tissue development(GO:1901862) |
0.4 | 1.1 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.4 | 1.5 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.4 | 1.9 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.4 | 3.0 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.4 | 21.2 | GO:0006413 | translational initiation(GO:0006413) |
0.4 | 0.4 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.4 | 0.7 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.4 | 1.5 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.4 | 1.1 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.4 | 0.7 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.4 | 3.3 | GO:0045022 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.4 | 1.1 | GO:0072283 | mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003337) metanephric renal vesicle morphogenesis(GO:0072283) |
0.4 | 2.2 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.4 | 3.0 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.4 | 0.7 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
0.4 | 2.6 | GO:0045116 | protein neddylation(GO:0045116) |
0.4 | 2.9 | GO:0007512 | adult heart development(GO:0007512) |
0.4 | 2.9 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.4 | 0.4 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.4 | 2.6 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.4 | 1.1 | GO:0070076 | histone lysine demethylation(GO:0070076) |
0.4 | 0.7 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.4 | 2.6 | GO:0030878 | thyroid gland development(GO:0030878) |
0.4 | 1.5 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.4 | 1.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.4 | 4.0 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.4 | 1.5 | GO:0010954 | positive regulation of protein processing(GO:0010954) positive regulation of protein maturation(GO:1903319) |
0.4 | 0.4 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.4 | 2.9 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.4 | 1.8 | GO:0002467 | germinal center formation(GO:0002467) |
0.4 | 1.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.4 | 5.4 | GO:0016925 | protein sumoylation(GO:0016925) |
0.4 | 1.4 | GO:0002097 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.4 | 1.1 | GO:0010842 | retina layer formation(GO:0010842) |
0.4 | 0.7 | GO:0016064 | immunoglobulin mediated immune response(GO:0016064) |
0.4 | 1.4 | GO:0051319 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.4 | 1.1 | GO:0045056 | transcytosis(GO:0045056) |
0.4 | 0.4 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.4 | 1.8 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.4 | 0.7 | GO:0008542 | visual learning(GO:0008542) |
0.4 | 4.3 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.4 | 0.7 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.4 | 7.8 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.4 | 1.1 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.4 | 1.4 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.4 | 1.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.4 | 0.4 | GO:0050854 | regulation of antigen receptor-mediated signaling pathway(GO:0050854) |
0.4 | 0.7 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.4 | 0.7 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.4 | 4.2 | GO:1900077 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.4 | 1.8 | GO:0019935 | cyclic-nucleotide-mediated signaling(GO:0019935) |
0.4 | 1.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.4 | 0.4 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.4 | 0.4 | GO:0034135 | regulation of toll-like receptor 2 signaling pathway(GO:0034135) |
0.4 | 1.8 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.4 | 1.1 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.3 | 3.1 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.3 | 3.1 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.3 | 1.0 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.3 | 2.8 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.3 | 1.0 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.3 | 1.0 | GO:0043248 | proteasome assembly(GO:0043248) |
0.3 | 0.7 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.3 | 0.7 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.3 | 1.4 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.3 | 0.7 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.3 | 0.7 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.3 | 0.3 | GO:0071503 | response to heparin(GO:0071503) |
0.3 | 0.7 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) |
0.3 | 0.3 | GO:0021515 | cell differentiation in spinal cord(GO:0021515) |
0.3 | 0.3 | GO:2001234 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.3 | 1.4 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.3 | 0.3 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
0.3 | 2.0 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.3 | 5.7 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.3 | 1.0 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.3 | 1.0 | GO:0031167 | rRNA methylation(GO:0031167) |
0.3 | 2.4 | GO:0048536 | spleen development(GO:0048536) |
0.3 | 2.3 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.3 | 0.7 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.3 | 1.3 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.3 | 0.7 | GO:0001302 | replicative cell aging(GO:0001302) |
0.3 | 1.0 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.3 | 1.0 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.3 | 0.3 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.3 | 0.7 | GO:0017014 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.3 | 3.0 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.3 | 1.0 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.3 | 0.3 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.3 | 1.7 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.3 | 3.3 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.3 | 1.3 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.3 | 0.7 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
0.3 | 0.7 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.3 | 0.7 | GO:0042637 | catagen(GO:0042637) |
0.3 | 0.3 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.3 | 3.6 | GO:0034620 | endoplasmic reticulum unfolded protein response(GO:0030968) cellular response to unfolded protein(GO:0034620) |
0.3 | 0.7 | GO:0060561 | apoptotic process involved in morphogenesis(GO:0060561) |
0.3 | 0.7 | GO:0001840 | neural plate morphogenesis(GO:0001839) neural plate development(GO:0001840) |
0.3 | 1.3 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.3 | 1.0 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.3 | 1.0 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.3 | 1.0 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.3 | 3.9 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.3 | 1.3 | GO:0045006 | DNA deamination(GO:0045006) |
0.3 | 0.3 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.3 | 0.3 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.3 | 1.0 | GO:0007000 | nucleolus organization(GO:0007000) |
0.3 | 0.6 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.3 | 0.6 | GO:0002724 | T cell cytokine production(GO:0002369) regulation of T cell cytokine production(GO:0002724) |
0.3 | 1.0 | GO:0006477 | protein sulfation(GO:0006477) |
0.3 | 0.6 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.3 | 0.3 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.3 | 0.6 | GO:0014048 | regulation of glutamate secretion(GO:0014048) positive regulation of amino acid transport(GO:0051957) |
0.3 | 1.0 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.3 | 0.6 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.3 | 4.7 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.3 | 1.3 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.3 | 1.6 | GO:0043368 | positive T cell selection(GO:0043368) |
0.3 | 1.6 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.3 | 0.6 | GO:0045576 | mast cell activation(GO:0045576) |
0.3 | 1.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.3 | 0.6 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.3 | 1.3 | GO:0006913 | nucleocytoplasmic transport(GO:0006913) |
0.3 | 0.6 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.3 | 0.9 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.3 | 5.3 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.3 | 2.5 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.3 | 3.7 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.3 | 0.3 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.3 | 0.9 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.3 | 0.9 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.3 | 0.6 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.3 | 0.3 | GO:0031667 | response to nutrient levels(GO:0031667) |
0.3 | 1.2 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.3 | 0.3 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.3 | 0.3 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.3 | 0.6 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.3 | 0.3 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.3 | 0.9 | GO:0034214 | protein hexamerization(GO:0034214) |
0.3 | 0.6 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.3 | 0.6 | GO:1901970 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.3 | 0.9 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.3 | 0.6 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
0.3 | 0.6 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.3 | 0.9 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.3 | 0.6 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.3 | 0.9 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.3 | 1.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.3 | 0.9 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.3 | 0.3 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.3 | 0.6 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.3 | 1.2 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.3 | 1.2 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.3 | 1.2 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
0.3 | 0.3 | GO:0048865 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.3 | 1.2 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.3 | 1.2 | GO:0050718 | positive regulation of interleukin-1 beta production(GO:0032731) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.3 | 1.2 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.3 | 1.2 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.3 | 1.5 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.3 | 0.9 | GO:0030091 | protein repair(GO:0030091) |
0.3 | 2.4 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.3 | 0.3 | GO:0007613 | memory(GO:0007613) |
0.3 | 1.2 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) |
0.3 | 13.6 | GO:0006968 | cellular defense response(GO:0006968) |
0.3 | 1.2 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.3 | 2.1 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.3 | 19.2 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.3 | 2.4 | GO:0060678 | dichotomous subdivision of terminal units involved in ureteric bud branching(GO:0060678) |
0.3 | 1.2 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.3 | 6.2 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.3 | 0.6 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.3 | 0.6 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.3 | 0.3 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.3 | 2.9 | GO:1903322 | positive regulation of protein ubiquitination(GO:0031398) positive regulation of protein modification by small protein conjugation or removal(GO:1903322) |
0.3 | 0.6 | GO:0016093 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.3 | 0.6 | GO:0032649 | regulation of interferon-gamma production(GO:0032649) |
0.3 | 0.9 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.3 | 2.0 | GO:1903321 | negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
0.3 | 1.2 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.3 | 0.6 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.3 | 26.6 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.3 | 0.6 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) positive regulation of response to cytokine stimulus(GO:0060760) |
0.3 | 3.5 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.3 | 1.4 | GO:0098657 | neurotransmitter uptake(GO:0001504) import into cell(GO:0098657) |
0.3 | 0.3 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.3 | 1.4 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.3 | 0.9 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.3 | 0.9 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.3 | 1.1 | GO:0042119 | granulocyte activation(GO:0036230) neutrophil activation(GO:0042119) |
0.3 | 2.6 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.3 | 0.9 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.3 | 11.4 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.3 | 0.3 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.3 | 1.1 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.3 | 11.7 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.3 | 0.3 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.3 | 0.6 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.3 | 5.4 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.3 | 1.4 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.3 | 2.3 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.3 | 1.4 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.3 | 0.3 | GO:0036314 | response to sterol(GO:0036314) cellular response to sterol(GO:0036315) response to cholesterol(GO:0070723) cellular response to cholesterol(GO:0071397) |
0.3 | 0.6 | GO:0060179 | male courtship behavior(GO:0008049) male mating behavior(GO:0060179) |
0.3 | 0.3 | GO:0031016 | pancreas development(GO:0031016) |
0.3 | 1.7 | GO:0035121 | obsolete tail morphogenesis(GO:0035121) |
0.3 | 0.8 | GO:0033144 | negative regulation of intracellular steroid hormone receptor signaling pathway(GO:0033144) |
0.3 | 0.3 | GO:0048145 | regulation of fibroblast proliferation(GO:0048145) positive regulation of fibroblast proliferation(GO:0048146) |
0.3 | 0.3 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.3 | 3.6 | GO:0097581 | lamellipodium assembly(GO:0030032) lamellipodium organization(GO:0097581) |
0.3 | 0.6 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.3 | 1.1 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.3 | 0.6 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.3 | 0.3 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.3 | 0.3 | GO:0002832 | negative regulation of response to biotic stimulus(GO:0002832) |
0.3 | 3.9 | GO:0043487 | regulation of RNA stability(GO:0043487) |
0.3 | 1.7 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.3 | 1.4 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.3 | 0.8 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.3 | 2.2 | GO:0006997 | nucleus organization(GO:0006997) |
0.3 | 0.3 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.3 | 4.4 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.3 | 0.3 | GO:0002063 | chondrocyte development(GO:0002063) |
0.3 | 0.8 | GO:0008354 | germ cell migration(GO:0008354) |
0.3 | 1.4 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
0.3 | 0.3 | GO:0060560 | developmental growth involved in morphogenesis(GO:0060560) |
0.3 | 0.3 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.3 | 0.3 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.3 | 0.8 | GO:0051182 | coenzyme transport(GO:0051182) |
0.3 | 0.3 | GO:0031529 | ruffle organization(GO:0031529) |
0.3 | 1.4 | GO:0002712 | regulation of B cell mediated immunity(GO:0002712) regulation of immunoglobulin mediated immune response(GO:0002889) |
0.3 | 0.3 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.3 | 0.5 | GO:0007632 | visual behavior(GO:0007632) |
0.3 | 0.5 | GO:0045932 | negative regulation of muscle contraction(GO:0045932) |
0.3 | 0.3 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.3 | 0.3 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.3 | 2.4 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.3 | 1.1 | GO:1904029 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.3 | 0.5 | GO:0043276 | anoikis(GO:0043276) |
0.3 | 0.5 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.3 | 0.5 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.3 | 9.9 | GO:0007498 | mesoderm development(GO:0007498) |
0.3 | 1.1 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.3 | 0.5 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.3 | 0.5 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.3 | 6.9 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
0.3 | 0.8 | GO:0006108 | malate metabolic process(GO:0006108) |
0.3 | 0.5 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.3 | 1.6 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.3 | 4.5 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.3 | 1.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.3 | 0.5 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
0.3 | 0.8 | GO:0042100 | B cell proliferation(GO:0042100) |
0.3 | 22.9 | GO:0045333 | cellular respiration(GO:0045333) |
0.3 | 2.9 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.3 | 0.5 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.3 | 0.5 | GO:0006323 | DNA packaging(GO:0006323) |
0.3 | 0.3 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.3 | 0.8 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.3 | 0.8 | GO:0034605 | cellular response to heat(GO:0034605) |
0.3 | 0.5 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.3 | 0.5 | GO:0097576 | vacuole fusion(GO:0097576) |
0.3 | 1.0 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.3 | 1.5 | GO:0006415 | translational termination(GO:0006415) |
0.3 | 1.0 | GO:0042113 | B cell activation(GO:0042113) |
0.3 | 0.8 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.3 | 0.8 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
0.3 | 1.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.3 | 3.6 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.3 | 0.8 | GO:0071636 | positive regulation of transforming growth factor beta production(GO:0071636) |
0.3 | 0.3 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
0.3 | 1.8 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.3 | 0.8 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.3 | 0.8 | GO:0071333 | cellular response to monosaccharide stimulus(GO:0071326) cellular response to hexose stimulus(GO:0071331) cellular response to glucose stimulus(GO:0071333) |
0.3 | 0.3 | GO:0019098 | reproductive behavior(GO:0019098) |
0.3 | 0.5 | GO:0009151 | purine deoxyribonucleotide metabolic process(GO:0009151) |
0.3 | 0.8 | GO:0032506 | cytokinetic process(GO:0032506) |
0.3 | 0.3 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.3 | 0.3 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.3 | 0.3 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.3 | 2.3 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.3 | 1.8 | GO:0097191 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.3 | 1.5 | GO:0034333 | adherens junction assembly(GO:0034333) |
0.3 | 0.3 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.3 | 1.5 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.3 | 0.3 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.3 | 0.8 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
0.3 | 3.5 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.3 | 1.8 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
0.3 | 0.3 | GO:0060433 | bronchus development(GO:0060433) |
0.3 | 2.5 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.3 | 3.0 | GO:0046794 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
0.3 | 0.8 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.2 | 2.7 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 0.7 | GO:0048488 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.2 | 0.2 | GO:0010822 | positive regulation of mitochondrion organization(GO:0010822) positive regulation of release of cytochrome c from mitochondria(GO:0090200) positive regulation of apoptotic signaling pathway(GO:2001235) |
0.2 | 0.7 | GO:0045007 | depurination(GO:0045007) |
0.2 | 1.2 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.2 | 1.0 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.2 | 1.2 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.2 | 1.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 0.2 | GO:0046323 | glucose import(GO:0046323) |
0.2 | 1.0 | GO:0009628 | response to abiotic stimulus(GO:0009628) |
0.2 | 0.7 | GO:0070489 | T cell activation(GO:0042110) leukocyte aggregation(GO:0070486) T cell aggregation(GO:0070489) lymphocyte aggregation(GO:0071593) |
0.2 | 6.9 | GO:0051017 | actin filament bundle assembly(GO:0051017) actin filament bundle organization(GO:0061572) |
0.2 | 0.7 | GO:0009405 | pathogenesis(GO:0009405) |
0.2 | 0.2 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
0.2 | 0.5 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.2 | 2.4 | GO:0045143 | synapsis(GO:0007129) homologous chromosome segregation(GO:0045143) chromosome organization involved in meiotic cell cycle(GO:0070192) |
0.2 | 0.7 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.2 | 1.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.2 | 0.7 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.2 | 1.5 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.2 | 0.2 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.2 | 1.7 | GO:0006465 | signal peptide processing(GO:0006465) |
0.2 | 0.5 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.2 | 3.2 | GO:0006400 | tRNA modification(GO:0006400) |
0.2 | 1.0 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.2 | 1.4 | GO:0045730 | respiratory burst(GO:0045730) |
0.2 | 1.2 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.2 | 0.2 | GO:0032743 | positive regulation of interleukin-2 production(GO:0032743) |
0.2 | 8.2 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.2 | 1.4 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.2 | 1.9 | GO:0045682 | regulation of epidermis development(GO:0045682) |
0.2 | 1.2 | GO:0007379 | segment specification(GO:0007379) |
0.2 | 2.6 | GO:0044843 | G1/S transition of mitotic cell cycle(GO:0000082) cell cycle G1/S phase transition(GO:0044843) |
0.2 | 0.7 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.2 | 1.0 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.2 | 0.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 0.5 | GO:0060487 | lung epithelial cell differentiation(GO:0060487) |
0.2 | 1.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.2 | 0.2 | GO:0021684 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.2 | 0.5 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.2 | 0.2 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
0.2 | 0.5 | GO:0031646 | positive regulation of neurological system process(GO:0031646) |
0.2 | 0.2 | GO:2000241 | regulation of reproductive process(GO:2000241) |
0.2 | 0.5 | GO:0009648 | photoperiodism(GO:0009648) |
0.2 | 0.7 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.2 | 0.7 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.2 | 0.7 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.2 | 0.5 | GO:0033077 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.2 | 0.5 | GO:0072698 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.2 | 4.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.2 | 0.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 0.5 | GO:0048535 | lymph node development(GO:0048535) |
0.2 | 0.2 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.2 | 2.6 | GO:0001558 | regulation of cell growth(GO:0001558) |
0.2 | 8.1 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.2 | 0.2 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.2 | 9.0 | GO:0051028 | mRNA transport(GO:0051028) |
0.2 | 18.5 | GO:0006414 | translational elongation(GO:0006414) |
0.2 | 1.2 | GO:0001660 | fever generation(GO:0001660) |
0.2 | 0.2 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.2 | 0.7 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.2 | 0.7 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.2 | 0.2 | GO:0098900 | regulation of action potential(GO:0098900) |
0.2 | 1.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.2 | 0.2 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.2 | 0.5 | GO:0019614 | phenol-containing compound catabolic process(GO:0019336) catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.2 | 0.5 | GO:0034371 | chylomicron remodeling(GO:0034371) |
0.2 | 1.8 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
0.2 | 0.9 | GO:0072506 | phosphate ion homeostasis(GO:0055062) divalent inorganic anion homeostasis(GO:0072505) trivalent inorganic anion homeostasis(GO:0072506) |
0.2 | 0.2 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.2 | 23.6 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
0.2 | 0.7 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.2 | 0.9 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.2 | 0.7 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.2 | 1.1 | GO:0015871 | choline transport(GO:0015871) |
0.2 | 3.6 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
0.2 | 0.7 | GO:0030516 | regulation of axon extension(GO:0030516) |
0.2 | 0.2 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) adenine salvage(GO:0006168) purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.2 | 0.9 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.2 | 0.2 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
0.2 | 2.4 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.2 | 3.6 | GO:0022406 | membrane docking(GO:0022406) |
0.2 | 2.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 1.8 | GO:0007422 | peripheral nervous system development(GO:0007422) |
0.2 | 6.2 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.2 | 0.4 | GO:0072079 | nephron tubule formation(GO:0072079) |
0.2 | 0.7 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.2 | 0.7 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.2 | 1.5 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.2 | 0.7 | GO:0032667 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.2 | 3.5 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.2 | 1.7 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.2 | 0.9 | GO:0060013 | righting reflex(GO:0060013) |
0.2 | 0.7 | GO:0048864 | stem cell development(GO:0048864) |
0.2 | 2.0 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.2 | 1.5 | GO:0010165 | response to X-ray(GO:0010165) |
0.2 | 0.4 | GO:0051299 | centrosome separation(GO:0051299) |
0.2 | 1.3 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 1.3 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.2 | 0.2 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.2 | 0.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.2 | 0.9 | GO:1903078 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.2 | 0.6 | GO:0009173 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.2 | 0.9 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.2 | 0.6 | GO:0006622 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.2 | 5.2 | GO:0033572 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.2 | 0.6 | GO:0021675 | nerve development(GO:0021675) |
0.2 | 0.2 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.2 | 1.1 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.2 | 1.1 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.2 | 11.7 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.2 | 0.2 | GO:0007530 | sex determination(GO:0007530) |
0.2 | 0.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 0.6 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.2 | 0.2 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.2 | 5.7 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.2 | 1.5 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.2 | 0.2 | GO:0006907 | pinocytosis(GO:0006907) |
0.2 | 3.8 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.2 | 0.4 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
0.2 | 0.4 | GO:0014741 | negative regulation of muscle hypertrophy(GO:0014741) |
0.2 | 2.1 | GO:0050663 | cytokine secretion(GO:0050663) |
0.2 | 1.3 | GO:0030238 | male sex determination(GO:0030238) |
0.2 | 0.4 | GO:0001892 | embryonic placenta development(GO:0001892) |
0.2 | 1.0 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.2 | 2.9 | GO:1903037 | regulation of T cell activation(GO:0050863) regulation of leukocyte cell-cell adhesion(GO:1903037) |
0.2 | 3.6 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.2 | 8.6 | GO:0000087 | mitotic M phase(GO:0000087) |
0.2 | 0.4 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.2 | 3.3 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.2 | 15.0 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.2 | 0.4 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.2 | 0.2 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.2 | 0.6 | GO:0000726 | non-recombinational repair(GO:0000726) |
0.2 | 1.0 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.2 | 0.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 1.9 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.2 | 0.4 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.2 | 44.9 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.2 | 1.2 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.2 | 0.8 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.2 | 0.4 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.2 | 0.8 | GO:0009953 | dorsal/ventral pattern formation(GO:0009953) |
0.2 | 0.2 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.2 | 1.2 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
0.2 | 0.2 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.2 | 4.3 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.2 | 2.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 3.0 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.2 | 1.4 | GO:0007416 | synapse assembly(GO:0007416) |
0.2 | 1.8 | GO:0015695 | organic cation transport(GO:0015695) |
0.2 | 4.0 | GO:1901185 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.2 | 0.2 | GO:0000154 | rRNA modification(GO:0000154) |
0.2 | 1.6 | GO:0008380 | RNA splicing(GO:0008380) |
0.2 | 0.4 | GO:0051654 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) establishment of mitochondrion localization(GO:0051654) |
0.2 | 0.2 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) |
0.2 | 1.0 | GO:1902099 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.2 | 3.8 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.2 | 0.8 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.2 | 1.6 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.2 | 36.0 | GO:0006412 | translation(GO:0006412) |
0.2 | 3.0 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 0.2 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.2 | 10.3 | GO:0008033 | tRNA processing(GO:0008033) |
0.2 | 0.4 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.2 | 0.2 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.2 | 1.2 | GO:0006818 | hydrogen transport(GO:0006818) |
0.2 | 0.2 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.2 | 1.6 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.2 | 0.2 | GO:0051276 | chromosome organization(GO:0051276) |
0.2 | 0.2 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.2 | 0.2 | GO:0042503 | tyrosine phosphorylation of Stat3 protein(GO:0042503) |
0.2 | 0.2 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.2 | 0.4 | GO:0051955 | regulation of amino acid transport(GO:0051955) |
0.2 | 1.1 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.2 | 2.7 | GO:0006026 | aminoglycan catabolic process(GO:0006026) glycosaminoglycan catabolic process(GO:0006027) |
0.2 | 1.7 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.2 | 5.5 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.2 | 1.5 | GO:0007398 | ectoderm development(GO:0007398) |
0.2 | 1.3 | GO:0006469 | negative regulation of protein kinase activity(GO:0006469) |
0.2 | 0.4 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.2 | 0.9 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.2 | 2.1 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.2 | 0.2 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.2 | 0.4 | GO:0001881 | receptor recycling(GO:0001881) |
0.2 | 0.4 | GO:0006473 | protein acetylation(GO:0006473) |
0.2 | 0.2 | GO:0009713 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.2 | 0.9 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.2 | 2.1 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.2 | 0.9 | GO:0042180 | cellular ketone metabolic process(GO:0042180) |
0.2 | 1.9 | GO:0009303 | rRNA transcription(GO:0009303) |
0.2 | 1.5 | GO:0007032 | endosome organization(GO:0007032) |
0.2 | 1.9 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.2 | 0.2 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.2 | 0.4 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.2 | 0.6 | GO:0034331 | cell junction maintenance(GO:0034331) cell-cell junction maintenance(GO:0045217) |
0.2 | 2.1 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.2 | 2.1 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.2 | 0.6 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.2 | 0.9 | GO:0048015 | phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
0.2 | 0.4 | GO:0048511 | rhythmic process(GO:0048511) |
0.2 | 7.1 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.2 | 0.7 | GO:0042246 | tissue regeneration(GO:0042246) |
0.2 | 0.2 | GO:0070918 | dsRNA fragmentation(GO:0031050) production of small RNA involved in gene silencing by RNA(GO:0070918) |
0.2 | 0.2 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.2 | 1.5 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.2 | 0.2 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.2 | 0.5 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.2 | 0.2 | GO:0048069 | eye pigmentation(GO:0048069) |
0.2 | 0.2 | GO:0016559 | peroxisome fission(GO:0016559) |
0.2 | 0.4 | GO:0034104 | negative regulation of tissue remodeling(GO:0034104) |
0.2 | 0.5 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.2 | 0.5 | GO:1903556 | negative regulation of tumor necrosis factor production(GO:0032720) negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
0.2 | 0.2 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.2 | 1.8 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.2 | 0.7 | GO:0010669 | epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
0.2 | 0.2 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.2 | 0.2 | GO:0021604 | cranial nerve structural organization(GO:0021604) facial nerve morphogenesis(GO:0021610) facial nerve structural organization(GO:0021612) anatomical structure arrangement(GO:0048532) |
0.2 | 0.4 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.2 | 0.7 | GO:0042471 | ear morphogenesis(GO:0042471) |
0.2 | 0.4 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.2 | 0.2 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) regulation of cell cycle G2/M phase transition(GO:1902749) |
0.2 | 0.4 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.2 | 1.1 | GO:0009607 | response to biotic stimulus(GO:0009607) |
0.2 | 0.7 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.2 | 0.2 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.2 | 1.6 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.2 | 0.3 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.2 | 0.9 | GO:0001838 | embryonic epithelial tube formation(GO:0001838) neural tube formation(GO:0001841) |
0.2 | 0.7 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.2 | 0.3 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.2 | 1.2 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.2 | 17.2 | GO:0016311 | dephosphorylation(GO:0016311) |
0.2 | 0.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.2 | 0.2 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.2 | 0.7 | GO:0051149 | positive regulation of muscle cell differentiation(GO:0051149) |
0.2 | 0.3 | GO:0046173 | polyol biosynthetic process(GO:0046173) |
0.2 | 0.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.2 | 0.9 | GO:0010001 | glial cell differentiation(GO:0010001) |
0.2 | 0.9 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.2 | 0.3 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.2 | 1.7 | GO:0031334 | positive regulation of protein complex assembly(GO:0031334) |
0.2 | 0.3 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.2 | 0.5 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.2 | 2.0 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.2 | 0.3 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.2 | 1.3 | GO:0046131 | pyrimidine ribonucleoside metabolic process(GO:0046131) |
0.2 | 4.0 | GO:0044782 | cilium organization(GO:0044782) |
0.2 | 0.2 | GO:0006200 | obsolete ATP catabolic process(GO:0006200) |
0.2 | 2.2 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.2 | 0.3 | GO:0040014 | regulation of multicellular organism growth(GO:0040014) |
0.2 | 4.9 | GO:0006914 | autophagy(GO:0006914) |
0.2 | 0.8 | GO:0007051 | spindle organization(GO:0007051) |
0.2 | 0.2 | GO:0019695 | choline metabolic process(GO:0019695) |
0.2 | 0.2 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.2 | 0.2 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.2 | 6.6 | GO:0007034 | vacuolar transport(GO:0007034) |
0.2 | 1.0 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.2 | 0.2 | GO:0035282 | segmentation(GO:0035282) |
0.2 | 0.8 | GO:0008217 | regulation of blood pressure(GO:0008217) |
0.2 | 2.5 | GO:0031647 | regulation of protein stability(GO:0031647) |
0.2 | 1.3 | GO:0051350 | negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) negative regulation of lyase activity(GO:0051350) |
0.2 | 0.5 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.2 | 0.5 | GO:0006390 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 0.2 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.2 | 0.2 | GO:0019724 | B cell mediated immunity(GO:0019724) |
0.2 | 1.4 | GO:0045666 | positive regulation of neuron differentiation(GO:0045666) |
0.2 | 3.9 | GO:0006310 | DNA recombination(GO:0006310) |
0.2 | 0.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.2 | 1.4 | GO:0016571 | histone methylation(GO:0016571) |
0.2 | 0.3 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.2 | 0.6 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.2 | 0.2 | GO:0006265 | DNA topological change(GO:0006265) |
0.2 | 0.2 | GO:0070254 | mucus secretion(GO:0070254) |
0.2 | 0.2 | GO:0032868 | response to insulin(GO:0032868) |
0.2 | 0.2 | GO:0060070 | canonical Wnt signaling pathway(GO:0060070) |
0.2 | 0.9 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.2 | 0.5 | GO:0061008 | hepaticobiliary system development(GO:0061008) |
0.2 | 0.9 | GO:0034762 | regulation of transmembrane transport(GO:0034762) |
0.2 | 19.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.2 | 0.5 | GO:0009820 | alkaloid metabolic process(GO:0009820) |
0.2 | 12.8 | GO:0006325 | chromatin organization(GO:0006325) |
0.2 | 0.2 | GO:0006312 | mitotic recombination(GO:0006312) |
0.2 | 0.2 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.2 | 0.2 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.2 | 0.5 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.2 | 0.3 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.2 | 0.3 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.2 | 14.7 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.2 | 12.4 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.2 | 1.4 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.2 | 0.3 | GO:0009408 | response to heat(GO:0009408) |
0.2 | 0.2 | GO:0032653 | regulation of interleukin-10 production(GO:0032653) |
0.2 | 0.5 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.2 | 3.2 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.2 | 1.5 | GO:0050832 | defense response to fungus(GO:0050832) |
0.2 | 0.5 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.2 | 0.5 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.2 | 0.2 | GO:0010506 | regulation of autophagy(GO:0010506) |
0.2 | 2.0 | GO:0016358 | dendrite development(GO:0016358) |
0.2 | 5.6 | GO:0009201 | nucleoside triphosphate biosynthetic process(GO:0009142) purine nucleoside triphosphate biosynthetic process(GO:0009145) ribonucleoside triphosphate biosynthetic process(GO:0009201) purine ribonucleoside triphosphate biosynthetic process(GO:0009206) |
0.2 | 0.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 0.8 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.2 | 8.0 | GO:0009615 | response to virus(GO:0009615) |
0.2 | 1.1 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.2 | 0.6 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.1 | 0.4 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.1 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.1 | 0.4 | GO:0009249 | protein lipoylation(GO:0009249) protein-cofactor linkage(GO:0018065) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.6 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous antigen(GO:0019883) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.1 | 1.3 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.1 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.1 | 0.3 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.1 | 0.1 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
0.1 | 0.3 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.4 | GO:0051297 | centrosome organization(GO:0051297) |
0.1 | 0.7 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 1.6 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.1 | 2.6 | GO:0006302 | double-strand break repair(GO:0006302) |
0.1 | 1.6 | GO:0046546 | male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
0.1 | 0.3 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 1.7 | GO:0022616 | DNA strand elongation(GO:0022616) |
0.1 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.1 | GO:0009804 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.1 | 0.7 | GO:0008213 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.1 | 4.2 | GO:0071773 | BMP signaling pathway(GO:0030509) response to BMP(GO:0071772) cellular response to BMP stimulus(GO:0071773) |
0.1 | 0.4 | GO:0030326 | embryonic limb morphogenesis(GO:0030326) embryonic appendage morphogenesis(GO:0035113) |
0.1 | 0.1 | GO:0006090 | pyruvate metabolic process(GO:0006090) |
0.1 | 3.4 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.1 | 1.0 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.1 | 0.7 | GO:0032200 | telomere organization(GO:0032200) |
0.1 | 1.0 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.1 | 5.0 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.1 | 0.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.4 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.1 | 1.4 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 0.1 | GO:0007616 | long-term memory(GO:0007616) |
0.1 | 0.6 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
0.1 | 0.4 | GO:0030856 | regulation of epithelial cell differentiation(GO:0030856) |
0.1 | 0.1 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 10.9 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.1 | 1.7 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.1 | 1.9 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
0.1 | 0.4 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) negative regulation of lipase activity(GO:0060192) |
0.1 | 0.6 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.1 | GO:0071600 | otic vesicle formation(GO:0030916) otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
0.1 | 0.3 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.1 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 1.8 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.1 | 0.4 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.1 | 0.1 | GO:0007127 | meiosis I(GO:0007127) |
0.1 | 1.1 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.1 | 0.5 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.1 | 0.9 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.1 | 0.4 | GO:0099518 | vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
0.1 | 0.3 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 0.8 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.1 | 0.1 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.1 | 0.4 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 0.4 | GO:0045740 | positive regulation of DNA replication(GO:0045740) |
0.1 | 0.1 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.1 | GO:1990778 | protein localization to plasma membrane(GO:0072659) protein localization to cell periphery(GO:1990778) |
0.1 | 0.1 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 0.6 | GO:0001570 | vasculogenesis(GO:0001570) |
0.1 | 1.4 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.1 | GO:0009749 | response to glucose(GO:0009749) |
0.1 | 0.1 | GO:0051289 | protein homotetramerization(GO:0051289) |
0.1 | 6.8 | GO:0022613 | ribonucleoprotein complex biogenesis(GO:0022613) |
0.1 | 5.6 | GO:0006959 | humoral immune response(GO:0006959) |
0.1 | 2.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.4 | GO:0048538 | thymus development(GO:0048538) |
0.1 | 11.2 | GO:0051603 | proteolysis involved in cellular protein catabolic process(GO:0051603) |
0.1 | 1.3 | GO:0050709 | negative regulation of protein secretion(GO:0050709) |
0.1 | 1.4 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.4 | GO:0006809 | nitric oxide biosynthetic process(GO:0006809) |
0.1 | 0.6 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.1 | 0.1 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.1 | 1.4 | GO:0045665 | negative regulation of neuron differentiation(GO:0045665) |
0.1 | 0.6 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 0.2 | GO:0030099 | myeloid cell differentiation(GO:0030099) |
0.1 | 0.2 | GO:0033483 | oxygen homeostasis(GO:0032364) gas homeostasis(GO:0033483) |
0.1 | 0.1 | GO:0042391 | regulation of membrane potential(GO:0042391) |
0.1 | 0.2 | GO:0021548 | pons development(GO:0021548) |
0.1 | 0.1 | GO:0042311 | vasodilation(GO:0042311) |
0.1 | 0.5 | GO:0006584 | catecholamine metabolic process(GO:0006584) catechol-containing compound metabolic process(GO:0009712) |
0.1 | 0.1 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.1 | 0.2 | GO:0035050 | embryonic heart tube development(GO:0035050) |
0.1 | 0.2 | GO:0021781 | glial cell fate commitment(GO:0021781) |
0.1 | 0.4 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.1 | 1.0 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.1 | 0.5 | GO:0007099 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.1 | 0.1 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.1 | 1.2 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.9 | GO:0006298 | mismatch repair(GO:0006298) |
0.1 | 1.2 | GO:0031638 | zymogen activation(GO:0031638) |
0.1 | 0.2 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.1 | 4.8 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.9 | GO:0007286 | spermatid development(GO:0007286) |
0.1 | 0.8 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 1.5 | GO:0061025 | membrane fusion(GO:0061025) |
0.1 | 1.7 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.1 | 0.9 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.1 | 1.8 | GO:0019400 | alditol metabolic process(GO:0019400) |
0.1 | 0.3 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.1 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 0.2 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 3.8 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.1 | 0.3 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.1 | 0.6 | GO:0010467 | gene expression(GO:0010467) |
0.1 | 4.2 | GO:0016567 | protein ubiquitination(GO:0016567) protein modification by small protein conjugation(GO:0032446) |
0.1 | 3.0 | GO:0007015 | actin filament organization(GO:0007015) |
0.1 | 0.1 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.1 | 0.6 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 1.4 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.1 | 2.4 | GO:0034339 | obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
0.1 | 2.2 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
0.1 | 0.8 | GO:0000097 | sulfur amino acid biosynthetic process(GO:0000097) methionine biosynthetic process(GO:0009086) |
0.1 | 16.6 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.1 | 1.2 | GO:0045926 | negative regulation of growth(GO:0045926) |
0.1 | 0.2 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 7.1 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 3.0 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.1 | 0.3 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
0.1 | 1.0 | GO:0006023 | aminoglycan biosynthetic process(GO:0006023) |
0.1 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.1 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.1 | 0.4 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.5 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.7 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 13.1 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.1 | 1.3 | GO:0097190 | apoptotic signaling pathway(GO:0097190) |
0.1 | 0.3 | GO:0085029 | extracellular matrix assembly(GO:0085029) |
0.1 | 0.1 | GO:0015853 | adenine transport(GO:0015853) |
0.1 | 0.1 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.1 | 0.1 | GO:0033135 | regulation of peptidyl-serine phosphorylation(GO:0033135) |
0.1 | 0.7 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.1 | 0.2 | GO:0015872 | dopamine transport(GO:0015872) |
0.1 | 0.8 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.1 | 0.4 | GO:0001906 | cell killing(GO:0001906) |
0.1 | 0.2 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.1 | 0.3 | GO:0002021 | response to dietary excess(GO:0002021) |
0.1 | 0.4 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 0.1 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.1 | 0.5 | GO:0034332 | adherens junction organization(GO:0034332) |
0.1 | 0.2 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.1 | 1.8 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.1 | 0.5 | GO:0031396 | regulation of protein ubiquitination(GO:0031396) |
0.1 | 0.8 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 1.5 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 0.1 | GO:0000042 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.1 | 1.0 | GO:0051302 | regulation of cell division(GO:0051302) |
0.1 | 0.2 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.1 | GO:0044091 | membrane biogenesis(GO:0044091) |
0.1 | 1.9 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.1 | 1.1 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.1 | 0.2 | GO:0001667 | ameboidal-type cell migration(GO:0001667) |
0.1 | 0.1 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.1 | 0.2 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.1 | 2.0 | GO:0006898 | receptor-mediated endocytosis(GO:0006898) |
0.1 | 0.1 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.1 | 0.7 | GO:0051051 | negative regulation of transport(GO:0051051) |
0.1 | 18.1 | GO:0006915 | apoptotic process(GO:0006915) |
0.1 | 0.1 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.1 | 93.0 | GO:0032774 | RNA biosynthetic process(GO:0032774) |
0.1 | 0.5 | GO:0009071 | glycine metabolic process(GO:0006544) glycine catabolic process(GO:0006546) serine family amino acid catabolic process(GO:0009071) |
0.1 | 1.7 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.1 | 0.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) guanosine-containing compound biosynthetic process(GO:1901070) |
0.1 | 1.6 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.1 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.1 | 2.2 | GO:0045786 | negative regulation of cell cycle(GO:0045786) |
0.1 | 0.2 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.5 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.1 | 0.2 | GO:0006906 | vesicle fusion(GO:0006906) |
0.1 | 0.2 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
0.1 | 0.1 | GO:0002329 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.1 | 2.0 | GO:0007338 | single fertilization(GO:0007338) |
0.1 | 0.1 | GO:2000113 | negative regulation of cellular macromolecule biosynthetic process(GO:2000113) |
0.1 | 0.1 | GO:0032612 | interleukin-1 production(GO:0032612) |
0.1 | 0.3 | GO:0014047 | glutamate secretion(GO:0014047) |
0.1 | 1.4 | GO:0007179 | transforming growth factor beta receptor signaling pathway(GO:0007179) |
0.1 | 0.4 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.4 | GO:0010043 | response to zinc ion(GO:0010043) |
0.1 | 0.4 | GO:0000050 | urea cycle(GO:0000050) |
0.1 | 0.5 | GO:1903305 | regulation of regulated secretory pathway(GO:1903305) |
0.1 | 0.5 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
0.1 | 2.1 | GO:0006644 | phospholipid metabolic process(GO:0006644) |
0.1 | 0.3 | GO:0006664 | glycolipid metabolic process(GO:0006664) |
0.1 | 0.3 | GO:0043526 | obsolete neuroprotection(GO:0043526) |
0.1 | 0.1 | GO:0050867 | positive regulation of cell activation(GO:0050867) |
0.1 | 0.4 | GO:0006833 | water transport(GO:0006833) |
0.1 | 0.4 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.1 | 0.5 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.1 | GO:0050920 | regulation of chemotaxis(GO:0050920) |
0.1 | 0.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.1 | GO:0046164 | alcohol catabolic process(GO:0046164) |
0.1 | 1.0 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.1 | 0.1 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.1 | 0.2 | GO:0051588 | regulation of neurotransmitter transport(GO:0051588) |
0.1 | 1.2 | GO:0000226 | microtubule cytoskeleton organization(GO:0000226) |
0.1 | 0.1 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.2 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.1 | 0.1 | GO:0001964 | startle response(GO:0001964) |
0.1 | 0.2 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.1 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.1 | 12.8 | GO:0006955 | immune response(GO:0006955) |
0.1 | 0.1 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.1 | 0.4 | GO:0002520 | immune system development(GO:0002520) |
0.1 | 0.2 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.1 | 0.3 | GO:0045927 | positive regulation of growth(GO:0045927) |
0.1 | 0.2 | GO:0044241 | lipid digestion(GO:0044241) |
0.1 | 0.5 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 0.6 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 0.1 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.1 | 0.3 | GO:0008366 | ensheathment of neurons(GO:0007272) axon ensheathment(GO:0008366) |
0.1 | 0.2 | GO:0006304 | DNA modification(GO:0006304) |
0.1 | 0.1 | GO:0042542 | response to hydrogen peroxide(GO:0042542) |
0.1 | 0.2 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.1 | 3.1 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.1 | 0.1 | GO:0071514 | genetic imprinting(GO:0071514) |
0.1 | 0.4 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.1 | 0.8 | GO:0006665 | sphingolipid metabolic process(GO:0006665) |
0.1 | 0.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.1 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.1 | 0.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.4 | GO:0006098 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.1 | 0.1 | GO:0042310 | vasoconstriction(GO:0042310) |
0.1 | 0.4 | GO:0009156 | nucleoside monophosphate biosynthetic process(GO:0009124) ribonucleoside monophosphate biosynthetic process(GO:0009156) |
0.1 | 0.5 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 2.0 | GO:0070085 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) glycosylation(GO:0070085) |
0.1 | 0.9 | GO:0055076 | transition metal ion homeostasis(GO:0055076) |
0.1 | 2.1 | GO:0007586 | digestion(GO:0007586) |
0.1 | 2.9 | GO:0006974 | cellular response to DNA damage stimulus(GO:0006974) |
0.1 | 0.3 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.1 | 0.6 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.1 | 0.1 | GO:0044764 | multi-organism cellular process(GO:0044764) |
0.1 | 0.1 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.1 | 4.9 | GO:0030168 | platelet activation(GO:0030168) |
0.1 | 0.3 | GO:0008361 | regulation of cell size(GO:0008361) |
0.1 | 1.2 | GO:0072655 | establishment of protein localization to mitochondrion(GO:0072655) |
0.1 | 0.2 | GO:0030730 | sequestering of triglyceride(GO:0030730) |
0.1 | 0.8 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.1 | GO:0043266 | regulation of potassium ion transport(GO:0043266) |
0.1 | 0.2 | GO:0010629 | negative regulation of gene expression(GO:0010629) |
0.1 | 0.2 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.1 | 2.7 | GO:0010876 | lipid localization(GO:0010876) |
0.1 | 0.1 | GO:0043254 | regulation of protein complex assembly(GO:0043254) |
0.1 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.2 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.9 | GO:0001503 | ossification(GO:0001503) |
0.1 | 0.2 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.1 | 1.4 | GO:0006816 | calcium ion transport(GO:0006816) |
0.1 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.1 | GO:0090150 | establishment of protein localization to membrane(GO:0090150) |
0.1 | 0.7 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
0.1 | 0.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.2 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.1 | 0.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.2 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.1 | 0.1 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 0.5 | GO:0032259 | methylation(GO:0032259) |
0.1 | 0.1 | GO:0019751 | polyol metabolic process(GO:0019751) |
0.1 | 0.1 | GO:0061430 | bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
0.1 | 12.6 | GO:0015031 | protein transport(GO:0015031) |
0.1 | 0.1 | GO:0051726 | regulation of cell cycle(GO:0051726) |
0.1 | 0.1 | GO:0034440 | fatty acid oxidation(GO:0019395) lipid oxidation(GO:0034440) |
0.1 | 0.1 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.1 | 0.2 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.9 | GO:0006396 | RNA processing(GO:0006396) |
0.1 | 0.1 | GO:0046849 | bone remodeling(GO:0046849) |
0.1 | 0.9 | GO:0006954 | inflammatory response(GO:0006954) |
0.1 | 0.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.1 | GO:0001656 | metanephros development(GO:0001656) |
0.1 | 0.2 | GO:0032956 | regulation of actin cytoskeleton organization(GO:0032956) |
0.1 | 0.1 | GO:0051095 | regulation of helicase activity(GO:0051095) |
0.1 | 0.4 | GO:0030817 | regulation of cAMP biosynthetic process(GO:0030817) |
0.1 | 0.1 | GO:0007204 | positive regulation of cytosolic calcium ion concentration(GO:0007204) |
0.1 | 0.6 | GO:0001523 | retinoid metabolic process(GO:0001523) diterpenoid metabolic process(GO:0016101) |
0.1 | 1.5 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.0 | 0.1 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.1 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.0 | 0.1 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.0 | 0.2 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.5 | GO:0030163 | protein catabolic process(GO:0030163) |
0.0 | 0.2 | GO:0007059 | chromosome segregation(GO:0007059) |
0.0 | 0.0 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.0 | 0.7 | GO:0048285 | organelle fission(GO:0048285) |
0.0 | 0.1 | GO:0032355 | response to estradiol(GO:0032355) |
0.0 | 0.1 | GO:0009309 | amine biosynthetic process(GO:0009309) |
0.0 | 0.2 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.0 | 1.0 | GO:0006865 | amino acid transport(GO:0006865) |
0.0 | 0.1 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.0 | GO:0009725 | response to hormone(GO:0009725) |
0.0 | 0.0 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) lymphocyte migration(GO:0072676) |
0.0 | 0.1 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.0 | 2.0 | GO:0050817 | coagulation(GO:0050817) |
0.0 | 0.0 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.0 | 0.0 | GO:0009266 | response to temperature stimulus(GO:0009266) |
0.0 | 0.0 | GO:0033673 | negative regulation of kinase activity(GO:0033673) |
0.0 | 0.4 | GO:0006986 | response to unfolded protein(GO:0006986) response to topologically incorrect protein(GO:0035966) |
0.0 | 0.1 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
0.0 | 0.1 | GO:0001508 | action potential(GO:0001508) |
0.0 | 0.1 | GO:0007620 | copulation(GO:0007620) |
0.0 | 0.5 | GO:0006260 | DNA replication(GO:0006260) |
0.0 | 3.0 | GO:0007283 | spermatogenesis(GO:0007283) male gamete generation(GO:0048232) |
0.0 | 1.9 | GO:0050953 | sensory perception of light stimulus(GO:0050953) |
0.0 | 0.1 | GO:0006775 | fat-soluble vitamin metabolic process(GO:0006775) |
0.0 | 1.6 | GO:0034220 | ion transmembrane transport(GO:0034220) |
0.0 | 0.3 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.0 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.0 | 0.3 | GO:0051260 | protein homooligomerization(GO:0051260) |
0.0 | 0.3 | GO:0042476 | odontogenesis(GO:0042476) |
0.0 | 1.4 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.0 | 0.9 | GO:0008219 | cell death(GO:0008219) |
0.0 | 0.0 | GO:0009880 | embryonic pattern specification(GO:0009880) |
0.0 | 0.1 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.0 | 0.0 | GO:0051789 | obsolete response to protein(GO:0051789) |
0.0 | 0.1 | GO:0032528 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.0 | 0.1 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 0.1 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
0.0 | 0.2 | GO:0031214 | biomineral tissue development(GO:0031214) |
0.0 | 0.1 | GO:0070206 | protein trimerization(GO:0070206) |
0.0 | 0.0 | GO:0015893 | drug transport(GO:0015893) |
0.0 | 0.1 | GO:0043269 | regulation of ion transport(GO:0043269) |
0.0 | 0.1 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 6.2 | GO:0007186 | G-protein coupled receptor signaling pathway(GO:0007186) |
0.0 | 1.4 | GO:0006952 | defense response(GO:0006952) |
0.0 | 1.4 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
0.0 | 0.3 | GO:0006826 | iron ion transport(GO:0006826) |
0.0 | 2.3 | GO:0035556 | intracellular signal transduction(GO:0035556) |
0.0 | 6.6 | GO:0016310 | phosphorylation(GO:0016310) |
0.0 | 0.4 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.0 | 0.0 | GO:0060041 | retina development in camera-type eye(GO:0060041) |
0.0 | 0.6 | GO:0006821 | chloride transport(GO:0006821) |
0.0 | 0.1 | GO:0048753 | pigment granule organization(GO:0048753) |
0.0 | 6.4 | GO:0006508 | proteolysis(GO:0006508) |
0.0 | 6.8 | GO:0007165 | signal transduction(GO:0007165) |
0.0 | 0.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.0 | GO:1903524 | positive regulation of blood circulation(GO:1903524) |
0.0 | 0.0 | GO:0046189 | phenol-containing compound biosynthetic process(GO:0046189) |
0.0 | 0.0 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.0 | 0.1 | GO:0007623 | circadian rhythm(GO:0007623) |
0.0 | 0.0 | GO:0060562 | epithelial tube morphogenesis(GO:0060562) |
0.0 | 0.1 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 1.2 | GO:0006813 | potassium ion transport(GO:0006813) |
0.0 | 2.0 | GO:0055085 | transmembrane transport(GO:0055085) |
0.0 | 0.0 | GO:0048705 | skeletal system morphogenesis(GO:0048705) |
0.0 | 7.4 | GO:0008152 | metabolic process(GO:0008152) |
0.0 | 0.0 | GO:0009593 | detection of chemical stimulus(GO:0009593) |
0.0 | 0.3 | GO:0008285 | negative regulation of cell proliferation(GO:0008285) |
0.0 | 4.5 | GO:0007608 | sensory perception of smell(GO:0007608) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
1.1 | 1.1 | GO:0012505 | endomembrane system(GO:0012505) |
1.1 | 1.1 | GO:0005921 | gap junction(GO:0005921) |
0.9 | 2.7 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.9 | 3.5 | GO:0043218 | compact myelin(GO:0043218) |
0.9 | 0.9 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.8 | 4.1 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.8 | 4.0 | GO:0016589 | NURF complex(GO:0016589) |
0.8 | 2.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.8 | 4.5 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.7 | 2.2 | GO:0072487 | MSL complex(GO:0072487) |
0.7 | 2.1 | GO:0032009 | early phagosome(GO:0032009) |
0.7 | 2.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.7 | 2.8 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.7 | 0.7 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.7 | 2.6 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.6 | 3.9 | GO:0000796 | condensin complex(GO:0000796) |
0.6 | 1.9 | GO:0001940 | male pronucleus(GO:0001940) |
0.6 | 5.1 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.6 | 1.9 | GO:0043083 | synaptic cleft(GO:0043083) |
0.6 | 3.1 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.6 | 1.7 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.6 | 5.2 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.6 | 6.3 | GO:0031519 | PcG protein complex(GO:0031519) |
0.6 | 0.6 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.6 | 4.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.6 | 7.8 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.6 | 0.6 | GO:0001726 | ruffle(GO:0001726) |
0.6 | 5.0 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.6 | 5.0 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.5 | 3.3 | GO:0042382 | paraspeckles(GO:0042382) |
0.5 | 3.2 | GO:0000791 | euchromatin(GO:0000791) |
0.5 | 3.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.5 | 1.5 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.5 | 2.0 | GO:0005827 | polar microtubule(GO:0005827) |
0.5 | 7.0 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.5 | 3.4 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.5 | 4.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.5 | 1.9 | GO:0005638 | lamin filament(GO:0005638) |
0.5 | 1.9 | GO:0005667 | transcription factor complex(GO:0005667) |
0.5 | 5.7 | GO:0031528 | microvillus membrane(GO:0031528) |
0.5 | 8.0 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.5 | 1.4 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.5 | 2.8 | GO:0042827 | platelet dense granule(GO:0042827) |
0.5 | 1.4 | GO:0001652 | granular component(GO:0001652) |
0.5 | 3.7 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.5 | 1.4 | GO:0031501 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.5 | 3.2 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.5 | 1.8 | GO:0000800 | lateral element(GO:0000800) |
0.4 | 1.8 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.4 | 2.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.4 | 1.3 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.4 | 4.0 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.4 | 3.9 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.4 | 0.8 | GO:0031932 | TORC2 complex(GO:0031932) |
0.4 | 1.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.4 | 1.6 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.4 | 1.6 | GO:0042587 | glycogen granule(GO:0042587) |
0.4 | 4.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.4 | 2.8 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.4 | 2.4 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.4 | 1.6 | GO:0001740 | Barr body(GO:0001740) |
0.4 | 2.4 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.4 | 1.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.4 | 23.0 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.4 | 1.9 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.4 | 1.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.4 | 0.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.4 | 1.5 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.4 | 1.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.4 | 1.5 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.4 | 0.8 | GO:0098562 | cytoplasmic side of membrane(GO:0098562) |
0.4 | 0.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.4 | 4.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.4 | 0.4 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.4 | 1.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.4 | 2.2 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.4 | 1.5 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.4 | 3.0 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.4 | 0.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.4 | 0.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.4 | 1.5 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.4 | 1.4 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.4 | 2.5 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.4 | 7.5 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.4 | 1.1 | GO:0005682 | U5 snRNP(GO:0005682) |
0.4 | 3.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.4 | 1.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 19.2 | GO:0031901 | early endosome membrane(GO:0031901) |
0.3 | 7.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.3 | 0.7 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.3 | 2.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.3 | 2.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.3 | 1.0 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.3 | 5.0 | GO:0090544 | BAF-type complex(GO:0090544) |
0.3 | 1.0 | GO:0031045 | dense core granule(GO:0031045) |
0.3 | 6.0 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.3 | 1.7 | GO:0000792 | heterochromatin(GO:0000792) |
0.3 | 1.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.3 | 7.3 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.3 | 8.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.3 | 2.3 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.3 | 1.0 | GO:0045120 | pronucleus(GO:0045120) |
0.3 | 1.0 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.3 | 17.9 | GO:0044815 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
0.3 | 3.6 | GO:0005657 | replication fork(GO:0005657) |
0.3 | 1.0 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.3 | 2.6 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.3 | 1.0 | GO:0042629 | mast cell granule(GO:0042629) |
0.3 | 15.4 | GO:0016605 | PML body(GO:0016605) |
0.3 | 0.6 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.3 | 1.3 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.3 | 1.9 | GO:0043209 | myelin sheath(GO:0043209) |
0.3 | 0.3 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.3 | 2.2 | GO:0000145 | exocyst(GO:0000145) |
0.3 | 0.6 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.3 | 2.2 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
0.3 | 5.0 | GO:0070461 | SAGA-type complex(GO:0070461) |
0.3 | 0.9 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.3 | 1.2 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.3 | 2.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 8.4 | GO:0030175 | filopodium(GO:0030175) |
0.3 | 24.2 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.3 | 0.9 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.3 | 0.3 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.3 | 2.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.3 | 1.5 | GO:0034451 | centriolar satellite(GO:0034451) |
0.3 | 0.9 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.3 | 0.6 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.3 | 1.8 | GO:0042555 | MCM complex(GO:0042555) |
0.3 | 5.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.3 | 19.0 | GO:0005643 | nuclear pore(GO:0005643) |
0.3 | 29.7 | GO:0016607 | nuclear speck(GO:0016607) |
0.3 | 5.0 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.3 | 11.3 | GO:0055037 | recycling endosome(GO:0055037) |
0.3 | 1.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.3 | 2.8 | GO:0031201 | SNARE complex(GO:0031201) |
0.3 | 5.1 | GO:0005776 | autophagosome(GO:0005776) |
0.3 | 1.4 | GO:0000346 | transcription export complex(GO:0000346) |
0.3 | 2.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 4.8 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.3 | 4.7 | GO:0000123 | histone acetyltransferase complex(GO:0000123) protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.3 | 0.8 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.3 | 0.8 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.3 | 0.8 | GO:0030904 | retromer complex(GO:0030904) |
0.3 | 1.9 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.3 | 0.3 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.3 | 5.2 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.3 | 0.3 | GO:0030870 | Mre11 complex(GO:0030870) |
0.3 | 7.9 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.3 | 0.3 | GO:0030686 | 90S preribosome(GO:0030686) |
0.3 | 5.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.3 | 0.8 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.3 | 0.8 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 1.3 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.3 | 1.8 | GO:0098533 | ATP-binding cassette (ABC) transporter complex(GO:0043190) ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.3 | 2.1 | GO:0005861 | troponin complex(GO:0005861) |
0.3 | 0.8 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.3 | 0.8 | GO:0070545 | PeBoW complex(GO:0070545) |
0.3 | 0.5 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.3 | 3.6 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.3 | 3.1 | GO:0032039 | integrator complex(GO:0032039) |
0.3 | 1.8 | GO:0042641 | actomyosin(GO:0042641) |
0.3 | 0.3 | GO:0000805 | X chromosome(GO:0000805) |
0.3 | 9.4 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.3 | 7.9 | GO:0016592 | mediator complex(GO:0016592) |
0.3 | 4.5 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.3 | 0.8 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.3 | 1.3 | GO:0030288 | outer membrane-bounded periplasmic space(GO:0030288) periplasmic space(GO:0042597) |
0.3 | 1.5 | GO:0005683 | U7 snRNP(GO:0005683) |
0.3 | 6.0 | GO:0005876 | spindle microtubule(GO:0005876) |
0.2 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 0.7 | GO:0032059 | bleb(GO:0032059) |
0.2 | 1.0 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 1.5 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 2.7 | GO:0005844 | polysome(GO:0005844) |
0.2 | 0.7 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.2 | 43.5 | GO:0005840 | ribosome(GO:0005840) |
0.2 | 0.7 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 2.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 0.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 0.5 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.2 | 9.3 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.2 | 0.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 5.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 0.7 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.2 | 0.7 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.2 | 2.8 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.2 | 1.6 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 2.8 | GO:0005839 | proteasome core complex(GO:0005839) |
0.2 | 2.1 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.2 | 3.7 | GO:0034399 | nuclear periphery(GO:0034399) |
0.2 | 3.3 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 1.2 | GO:0045179 | apical cortex(GO:0045179) |
0.2 | 2.5 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.2 | 1.6 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.2 | 1.4 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 5.5 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 10.5 | GO:0000776 | kinetochore(GO:0000776) |
0.2 | 8.6 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.2 | 7.7 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 8.6 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 1.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.2 | 0.5 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.2 | 0.9 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.2 | 0.4 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 10.5 | GO:0005769 | early endosome(GO:0005769) |
0.2 | 0.9 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 12.3 | GO:0000785 | chromatin(GO:0000785) |
0.2 | 1.1 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.2 | 1.7 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.2 | 0.9 | GO:0060076 | excitatory synapse(GO:0060076) |
0.2 | 1.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 1.1 | GO:0032590 | dendrite membrane(GO:0032590) |
0.2 | 0.9 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.2 | 0.4 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 2.5 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 1.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.2 | 8.2 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.2 | 1.9 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 1.0 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 2.5 | GO:0019717 | obsolete synaptosome(GO:0019717) |
0.2 | 0.8 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.2 | 2.7 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.2 | 0.4 | GO:0030897 | HOPS complex(GO:0030897) |
0.2 | 0.6 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 0.4 | GO:0038201 | TORC1 complex(GO:0031931) TOR complex(GO:0038201) |
0.2 | 1.4 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 17.0 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.2 | 0.6 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 0.4 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.2 | 19.9 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.2 | 277.0 | GO:0005829 | cytosol(GO:0005829) |
0.2 | 4.8 | GO:0005770 | late endosome(GO:0005770) |
0.2 | 33.3 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.2 | 4.3 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 8.9 | GO:0005819 | spindle(GO:0005819) |
0.2 | 1.3 | GO:0044441 | ciliary part(GO:0044441) |
0.2 | 1.7 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.2 | 43.7 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.2 | 0.4 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 58.7 | GO:0005654 | nucleoplasm(GO:0005654) |
0.2 | 0.2 | GO:0043296 | apical junction complex(GO:0043296) |
0.2 | 1.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.2 | 96.1 | GO:0005739 | mitochondrion(GO:0005739) |
0.2 | 2.7 | GO:0031300 | intrinsic component of organelle membrane(GO:0031300) |
0.2 | 0.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 2.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 16.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.2 | 0.7 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 1.1 | GO:0030496 | midbody(GO:0030496) |
0.2 | 1.0 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.2 | 45.5 | GO:0000139 | Golgi membrane(GO:0000139) |
0.2 | 0.9 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 85.3 | GO:0005730 | nucleolus(GO:0005730) |
0.2 | 1.7 | GO:0031090 | organelle membrane(GO:0031090) |
0.2 | 0.5 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.2 | 2.9 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.2 | 0.3 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.2 | 10.3 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.2 | 3.6 | GO:0010008 | endosome membrane(GO:0010008) |
0.2 | 1.2 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.2 | 386.2 | GO:0005634 | nucleus(GO:0005634) |
0.2 | 0.7 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 0.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 0.3 | GO:0033268 | node of Ranvier(GO:0033268) |
0.2 | 49.3 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.2 | 0.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 4.0 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.2 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 2.4 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 2.3 | GO:0072372 | primary cilium(GO:0072372) |
0.1 | 0.3 | GO:0030427 | growth cone(GO:0030426) site of polarized growth(GO:0030427) |
0.1 | 19.6 | GO:0009986 | cell surface(GO:0009986) |
0.1 | 1.3 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 1.7 | GO:0042612 | MHC protein complex(GO:0042611) MHC class I protein complex(GO:0042612) |
0.1 | 4.6 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 2.6 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.1 | 0.7 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 0.4 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 3.4 | GO:0005624 | obsolete membrane fraction(GO:0005624) |
0.1 | 0.5 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 10.0 | GO:0030659 | cytoplasmic vesicle membrane(GO:0030659) |
0.1 | 22.7 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 1.5 | GO:1990904 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.1 | 0.5 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.1 | 0.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.5 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 6.2 | GO:0044297 | neuronal cell body(GO:0043025) cell body(GO:0044297) |
0.1 | 0.4 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.4 | GO:1990234 | transferase complex(GO:1990234) |
0.1 | 4.5 | GO:0030424 | axon(GO:0030424) |
0.1 | 0.4 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 11.1 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.1 | 0.2 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 9.1 | GO:0005874 | microtubule(GO:0005874) |
0.1 | 0.3 | GO:0043005 | neuron projection(GO:0043005) |
0.1 | 1.7 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.1 | 281.0 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 0.4 | GO:0005792 | obsolete microsome(GO:0005792) |
0.1 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.4 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 0.5 | GO:0044291 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.1 | 0.1 | GO:0036379 | myofilament(GO:0036379) |
0.1 | 87.4 | GO:0005737 | cytoplasm(GO:0005737) |
0.1 | 0.1 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.3 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.2 | GO:0005911 | cell-cell junction(GO:0005911) |
0.1 | 27.6 | GO:0005622 | intracellular(GO:0005622) |
0.1 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.1 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.1 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.0 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
0.0 | 0.0 | GO:0098794 | postsynapse(GO:0098794) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 1.3 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
1.1 | 3.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
1.0 | 4.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
1.0 | 3.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
1.0 | 3.0 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
1.0 | 2.0 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
1.0 | 3.0 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
1.0 | 3.0 | GO:0004966 | galanin receptor activity(GO:0004966) |
1.0 | 2.9 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
1.0 | 3.9 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.9 | 2.8 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.9 | 0.9 | GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen(GO:0016705) |
0.9 | 3.6 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.9 | 5.5 | GO:0050733 | RS domain binding(GO:0050733) |
0.8 | 2.5 | GO:0005113 | patched binding(GO:0005113) |
0.8 | 2.5 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.8 | 3.3 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.8 | 4.9 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.8 | 1.6 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.8 | 0.8 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.8 | 2.4 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) |
0.8 | 2.3 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.8 | 2.3 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.8 | 6.9 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.8 | 2.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.8 | 2.3 | GO:0052659 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.7 | 0.7 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.7 | 2.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.7 | 1.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.7 | 0.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.7 | 0.7 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.7 | 1.4 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.7 | 3.5 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.7 | 0.7 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.7 | 8.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.7 | 2.0 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.7 | 8.7 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.7 | 2.7 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.7 | 2.0 | GO:0000339 | RNA cap binding(GO:0000339) |
0.7 | 2.7 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.7 | 2.6 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.6 | 0.6 | GO:0003896 | DNA primase activity(GO:0003896) |
0.6 | 2.6 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.6 | 1.9 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.6 | 1.9 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.6 | 3.8 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.6 | 0.6 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.6 | 1.9 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.6 | 6.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.6 | 2.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.6 | 1.9 | GO:0031014 | troponin T binding(GO:0031014) |
0.6 | 2.5 | GO:0030911 | TPR domain binding(GO:0030911) |
0.6 | 1.8 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.6 | 3.1 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.6 | 3.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.6 | 3.7 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.6 | 1.8 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.6 | 1.8 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.6 | 1.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.6 | 1.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.6 | 2.4 | GO:0004064 | arylesterase activity(GO:0004064) |
0.6 | 1.8 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.6 | 0.6 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.6 | 4.0 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.6 | 1.7 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.6 | 1.7 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.6 | 5.7 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.6 | 4.0 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.6 | 2.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.6 | 4.5 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.6 | 1.7 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.6 | 2.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.6 | 0.6 | GO:0001159 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.6 | 3.3 | GO:0005521 | lamin binding(GO:0005521) |
0.6 | 6.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.6 | 4.4 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.5 | 1.6 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.5 | 2.2 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.5 | 2.2 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.5 | 2.1 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.5 | 2.1 | GO:0030172 | troponin C binding(GO:0030172) |
0.5 | 3.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.5 | 1.1 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.5 | 1.6 | GO:0043398 | HLH domain binding(GO:0043398) |
0.5 | 2.6 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.5 | 1.0 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.5 | 5.2 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.5 | 1.0 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.5 | 2.0 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.5 | 1.5 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.5 | 1.5 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.5 | 1.5 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.5 | 2.5 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.5 | 1.5 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.5 | 1.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.5 | 0.5 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.5 | 1.5 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.5 | 8.9 | GO:0043621 | protein self-association(GO:0043621) |
0.5 | 2.0 | GO:0015925 | galactosidase activity(GO:0015925) |
0.5 | 1.5 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.5 | 1.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.5 | 3.4 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.5 | 2.4 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.5 | 6.6 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.5 | 1.4 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.5 | 2.4 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.5 | 0.5 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.5 | 1.4 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.5 | 1.9 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.5 | 6.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.5 | 1.9 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.5 | 0.5 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.5 | 1.8 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.5 | 1.4 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.5 | 1.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.5 | 1.4 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.5 | 1.4 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.5 | 13.1 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.4 | 1.8 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.4 | 1.8 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.4 | 1.3 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.4 | 0.4 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.4 | 4.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.4 | 2.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.4 | 4.4 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.4 | 0.9 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.4 | 1.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.4 | 2.6 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.4 | 2.2 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.4 | 2.6 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.4 | 3.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.4 | 2.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.4 | 0.9 | GO:0000976 | transcription regulatory region sequence-specific DNA binding(GO:0000976) |
0.4 | 0.9 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.4 | 2.6 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.4 | 6.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.4 | 4.7 | GO:0019201 | nucleotide kinase activity(GO:0019201) |
0.4 | 2.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.4 | 1.3 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.4 | 7.6 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.4 | 0.8 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.4 | 1.7 | GO:0045569 | TRAIL binding(GO:0045569) |
0.4 | 0.8 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.4 | 0.4 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.4 | 0.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.4 | 2.9 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.4 | 3.3 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.4 | 3.7 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.4 | 9.4 | GO:0002039 | p53 binding(GO:0002039) |
0.4 | 1.2 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.4 | 5.7 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.4 | 2.0 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.4 | 1.6 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.4 | 1.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.4 | 1.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.4 | 19.3 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.4 | 0.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.4 | 0.8 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.4 | 2.0 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.4 | 1.2 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.4 | 1.2 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.4 | 1.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.4 | 2.7 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.4 | 0.8 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.4 | 2.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.4 | 7.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.4 | 6.5 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.4 | 1.5 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.4 | 1.5 | GO:0016208 | AMP binding(GO:0016208) |
0.4 | 0.4 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.4 | 2.3 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.4 | 1.1 | GO:0017069 | snRNA binding(GO:0017069) |
0.4 | 0.8 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.4 | 1.5 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.4 | 9.3 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.4 | 1.8 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.4 | 1.5 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.4 | 1.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.4 | 1.1 | GO:0004875 | complement receptor activity(GO:0004875) |
0.4 | 1.8 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.4 | 0.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.4 | 0.7 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.4 | 2.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.4 | 4.7 | GO:0005035 | death receptor activity(GO:0005035) |
0.4 | 5.1 | GO:0070888 | E-box binding(GO:0070888) |
0.4 | 1.4 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.4 | 6.5 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.4 | 1.1 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.4 | 1.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.4 | 3.9 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.4 | 2.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.4 | 1.4 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.4 | 1.1 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.4 | 2.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.4 | 2.1 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.4 | 20.0 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.4 | 0.4 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.4 | 1.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.4 | 1.1 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.3 | 1.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.3 | 1.0 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.3 | 2.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.3 | 10.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.3 | 3.5 | GO:0030276 | clathrin binding(GO:0030276) |
0.3 | 0.3 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.3 | 1.0 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.3 | 13.4 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.3 | 1.7 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.3 | 1.0 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.3 | 1.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.3 | 0.3 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.3 | 1.3 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.3 | 1.3 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.3 | 2.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.3 | 1.3 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.3 | 5.0 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.3 | 2.0 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.3 | 3.3 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.3 | 1.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.3 | 2.3 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.3 | 1.0 | GO:0005346 | purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.3 | 0.3 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.3 | 4.0 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.3 | 1.6 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.3 | 1.0 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.3 | 2.0 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.3 | 0.7 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.3 | 1.6 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.3 | 1.6 | GO:0004568 | chitinase activity(GO:0004568) |
0.3 | 2.9 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.3 | 1.0 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.3 | 0.6 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.3 | 1.6 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.3 | 1.0 | GO:0004103 | choline kinase activity(GO:0004103) |
0.3 | 0.6 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.3 | 1.6 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 1.0 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.3 | 0.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.3 | 7.6 | GO:0019003 | GDP binding(GO:0019003) |
0.3 | 1.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.3 | 0.9 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.3 | 0.9 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.3 | 0.6 | GO:0031013 | troponin I binding(GO:0031013) |
0.3 | 1.6 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.3 | 1.9 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.3 | 6.5 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.3 | 0.9 | GO:0008061 | chitin binding(GO:0008061) |
0.3 | 2.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.3 | 1.2 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.3 | 1.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.3 | 1.5 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.3 | 2.1 | GO:0001228 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.3 | 1.2 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.3 | 2.7 | GO:0030553 | cGMP binding(GO:0030553) |
0.3 | 1.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.3 | 1.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.3 | 0.9 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.3 | 1.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.3 | 0.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.3 | 0.9 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.3 | 1.2 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.3 | 13.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 3.5 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.3 | 1.8 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.3 | 1.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.3 | 1.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.3 | 2.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.3 | 4.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.3 | 0.3 | GO:0015421 | oligopeptide-transporting ATPase activity(GO:0015421) |
0.3 | 0.9 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.3 | 0.9 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.3 | 1.2 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.3 | 0.9 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.3 | 2.9 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.3 | 0.3 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.3 | 4.6 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.3 | 4.9 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.3 | 2.6 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.3 | 1.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.3 | 1.1 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.3 | 3.7 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.3 | 0.9 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.3 | 0.3 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.3 | 6.5 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.3 | 2.0 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.3 | 0.8 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.3 | 0.6 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.3 | 1.4 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.3 | 0.6 | GO:0042287 | MHC protein binding(GO:0042287) |
0.3 | 3.4 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.3 | 0.6 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.3 | 1.4 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.3 | 2.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.3 | 0.6 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.3 | 2.0 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.3 | 1.7 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.3 | 0.6 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.3 | 9.4 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.3 | 1.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.3 | 1.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 0.8 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.3 | 0.3 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.3 | 0.8 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.3 | 1.9 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 0.5 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.3 | 0.8 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.3 | 0.3 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.3 | 0.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.3 | 1.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.3 | 5.7 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.3 | 1.9 | GO:0030371 | translation repressor activity(GO:0030371) |
0.3 | 0.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.3 | 1.6 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.3 | 1.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.3 | 5.6 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.3 | 1.6 | GO:0030332 | cyclin binding(GO:0030332) |
0.3 | 69.4 | GO:0016563 | obsolete transcription activator activity(GO:0016563) |
0.3 | 1.6 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.3 | 0.8 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.3 | 6.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 1.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.3 | 0.5 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.3 | 1.8 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.3 | 1.3 | GO:0001846 | opsonin binding(GO:0001846) |
0.3 | 12.6 | GO:0003700 | transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.3 | 4.7 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.3 | 1.0 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.3 | 0.8 | GO:0004802 | transketolase activity(GO:0004802) |
0.3 | 1.6 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.3 | 0.3 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.3 | 0.8 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.3 | 0.8 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.3 | 2.8 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.3 | 3.1 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.3 | 1.0 | GO:0052742 | phosphatidylinositol kinase activity(GO:0052742) |
0.3 | 4.6 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.3 | 0.3 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.3 | 9.1 | GO:0008137 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.3 | 1.3 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.3 | 0.8 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.3 | 1.8 | GO:0030507 | spectrin binding(GO:0030507) |
0.3 | 4.0 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.3 | 3.5 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.3 | 0.5 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.2 | 3.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 2.7 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.2 | 0.5 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.2 | 8.2 | GO:0015662 | ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism(GO:0015662) |
0.2 | 0.2 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.2 | 0.7 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.2 | 6.6 | GO:0004871 | signal transducer activity(GO:0004871) |
0.2 | 6.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.2 | 0.7 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 2.7 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.2 | 2.2 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.2 | 0.5 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.2 | 2.0 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.2 | 0.7 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.2 | 1.0 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 0.5 | GO:0001848 | complement binding(GO:0001848) |
0.2 | 1.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 1.2 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.2 | 1.9 | GO:0051117 | ATPase binding(GO:0051117) |
0.2 | 3.6 | GO:0016878 | acid-thiol ligase activity(GO:0016878) |
0.2 | 1.9 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.2 | 1.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 5.0 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.2 | 2.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 0.7 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.2 | 0.7 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.2 | 23.3 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.2 | 0.9 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.2 | 3.0 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 0.9 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 0.7 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.2 | 0.7 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.2 | 2.6 | GO:0004835 | tubulin-tyrosine ligase activity(GO:0004835) |
0.2 | 0.7 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.2 | 7.9 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.2 | 1.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.2 | 0.2 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.2 | 3.9 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.2 | 1.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 3.0 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.2 | 0.5 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.2 | 1.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 1.8 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.2 | 4.5 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.2 | 0.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.2 | 1.4 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.2 | 0.7 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.2 | 1.6 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.2 | 0.9 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.2 | 32.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 0.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 1.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 1.6 | GO:0019843 | rRNA binding(GO:0019843) |
0.2 | 1.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 7.6 | GO:1901981 | phosphatidylinositol phosphate binding(GO:1901981) |
0.2 | 2.5 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.2 | 0.4 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.2 | 1.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 0.4 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.2 | 1.3 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.2 | 0.4 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 2.0 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.2 | 0.9 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.2 | 1.5 | GO:0035064 | methylated histone binding(GO:0035064) |
0.2 | 2.0 | GO:0019864 | IgG binding(GO:0019864) |
0.2 | 1.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.2 | 3.3 | GO:0060589 | nucleoside-triphosphatase regulator activity(GO:0060589) |
0.2 | 0.9 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.2 | 0.9 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 0.4 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.2 | 0.6 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 0.6 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.2 | 1.9 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 0.2 | GO:0046915 | transition metal ion transmembrane transporter activity(GO:0046915) |
0.2 | 0.6 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.2 | 1.9 | GO:0042171 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.2 | 4.9 | GO:0016566 | obsolete specific transcriptional repressor activity(GO:0016566) |
0.2 | 2.6 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.2 | 4.1 | GO:0042625 | ATPase coupled ion transmembrane transporter activity(GO:0042625) |
0.2 | 1.3 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
0.2 | 7.5 | GO:0003682 | chromatin binding(GO:0003682) |
0.2 | 8.3 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
0.2 | 0.4 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.2 | 4.0 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.2 | 2.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.2 | 1.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 0.4 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 2.7 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.2 | 0.6 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 4.4 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 11.5 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.2 | 0.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.2 | 1.0 | GO:0032451 | demethylase activity(GO:0032451) |
0.2 | 0.6 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.2 | 3.9 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.2 | 1.0 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.2 | 0.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.2 | 0.4 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 9.0 | GO:0008017 | microtubule binding(GO:0008017) |
0.2 | 0.2 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.2 | 1.0 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 2.4 | GO:0016896 | exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.2 | 1.2 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.2 | 1.6 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.2 | 1.6 | GO:0030515 | snoRNA binding(GO:0030515) |
0.2 | 2.8 | GO:0004527 | exonuclease activity(GO:0004527) |
0.2 | 3.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 1.4 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 1.2 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.2 | 0.2 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.2 | 3.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.2 | 2.8 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.2 | 1.4 | GO:0030275 | LRR domain binding(GO:0030275) |
0.2 | 0.2 | GO:0042806 | fucose binding(GO:0042806) |
0.2 | 0.2 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.2 | 2.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 5.1 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.2 | 1.6 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.2 | 0.8 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.2 | 1.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 1.0 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.2 | 1.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.2 | 0.2 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.2 | 0.4 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.2 | 0.8 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.2 | 0.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.2 | 0.8 | GO:0016803 | epoxide hydrolase activity(GO:0004301) ether hydrolase activity(GO:0016803) |
0.2 | 0.2 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.2 | 1.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.2 | 3.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 0.6 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.2 | 0.8 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.2 | 4.9 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.2 | 1.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.2 | 0.6 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.2 | 0.4 | GO:0031404 | chloride ion binding(GO:0031404) |
0.2 | 1.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.2 | 0.4 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.2 | 0.4 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.2 | 1.9 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.2 | 2.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.2 | 1.7 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 0.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 2.8 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.2 | 14.7 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.2 | 0.2 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.2 | 1.1 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.2 | 0.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 0.4 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 272.9 | GO:0003677 | DNA binding(GO:0003677) |
0.2 | 0.9 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 1.6 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.2 | 61.1 | GO:0003723 | RNA binding(GO:0003723) |
0.2 | 2.5 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.2 | 3.2 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.2 | 0.5 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.2 | 1.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 0.2 | GO:0016595 | glutamate binding(GO:0016595) |
0.2 | 2.1 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.2 | 0.4 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.2 | 2.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 1.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 2.1 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.2 | 0.9 | GO:0019894 | kinesin binding(GO:0019894) |
0.2 | 1.2 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.2 | 0.7 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.2 | 0.5 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.2 | 3.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 4.8 | GO:0051540 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.2 | 0.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 1.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 0.3 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.2 | 1.0 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.2 | 0.8 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.2 | 1.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 0.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 0.3 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.2 | 1.0 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.2 | 1.3 | GO:0030145 | manganese ion binding(GO:0030145) |
0.2 | 0.7 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.2 | 1.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 3.3 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.2 | 0.8 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.2 | 0.2 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.2 | 1.0 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 2.6 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.2 | 0.8 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.2 | 1.0 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.2 | 0.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 5.7 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.2 | 0.3 | GO:0016715 | dopamine beta-monooxygenase activity(GO:0004500) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.2 | 7.0 | GO:0051020 | GTPase binding(GO:0051020) |
0.2 | 2.1 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.2 | 2.4 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 0.3 | GO:0035173 | histone kinase activity(GO:0035173) |
0.2 | 0.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 11.1 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.2 | 3.7 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.2 | 2.9 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.2 | 3.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 0.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.2 | 0.6 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.2 | 0.5 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.2 | 28.0 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.2 | 0.8 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 0.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 1.9 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.2 | 0.5 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.2 | 0.6 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.2 | 0.8 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.2 | 0.8 | GO:0004396 | hexokinase activity(GO:0004396) |
0.2 | 1.5 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 1.8 | GO:0004175 | endopeptidase activity(GO:0004175) |
0.1 | 1.3 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.7 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.1 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.1 | 2.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 37.3 | GO:0005525 | GTP binding(GO:0005525) guanyl nucleotide binding(GO:0019001) guanyl ribonucleotide binding(GO:0032561) |
0.1 | 0.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.6 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.4 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 8.2 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 2.4 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.6 | GO:0080031 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.1 | 0.7 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.1 | 0.4 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 2.1 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 1.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.4 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.1 | 1.4 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.1 | 1.0 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.1 | 0.3 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.3 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.1 | 0.1 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 10.8 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 13.2 | GO:0016874 | ligase activity(GO:0016874) |
0.1 | 0.5 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.4 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 1.0 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 2.2 | GO:0008144 | drug binding(GO:0008144) |
0.1 | 0.5 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.8 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.3 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.1 | 0.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 1.1 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.9 | GO:0005048 | signal sequence binding(GO:0005048) |
0.1 | 2.4 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 0.3 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.1 | 3.4 | GO:0015370 | solute:sodium symporter activity(GO:0015370) |
0.1 | 0.5 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 25.1 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 1.0 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.1 | 19.3 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.1 | 0.6 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.1 | 9.0 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 0.3 | GO:0035240 | dopamine binding(GO:0035240) |
0.1 | 7.9 | GO:0019900 | kinase binding(GO:0019900) |
0.1 | 0.9 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.8 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.6 | GO:0022884 | protein transmembrane transporter activity(GO:0008320) macromolecule transmembrane transporter activity(GO:0022884) |
0.1 | 0.2 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.7 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 0.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 2.7 | GO:0004601 | peroxidase activity(GO:0004601) oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.1 | 0.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 1.5 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.4 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.1 | 0.5 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 1.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 1.1 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.1 | 0.6 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 1.5 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.1 | 2.0 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.2 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 1.5 | GO:0016835 | carbon-oxygen lyase activity(GO:0016835) |
0.1 | 0.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 3.4 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.1 | 6.4 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.1 | 0.6 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.1 | 0.5 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.1 | 0.3 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.3 | GO:0097493 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 6.1 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.1 | 0.7 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 0.3 | GO:0019209 | kinase activator activity(GO:0019209) |
0.1 | 0.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.7 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 1.0 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.1 | 0.4 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.5 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 4.4 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.1 | 0.3 | GO:0005497 | androgen binding(GO:0005497) |
0.1 | 0.4 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.2 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 0.6 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 2.2 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.4 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.7 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.1 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 0.1 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 2.3 | GO:0008134 | transcription factor binding(GO:0008134) |
0.1 | 6.7 | GO:0016746 | transferase activity, transferring acyl groups(GO:0016746) |
0.1 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.4 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.1 | 0.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.7 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.9 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 0.1 | GO:0060229 | lipase activator activity(GO:0060229) |
0.1 | 0.8 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.1 | 0.5 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 4.2 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.5 | GO:0017171 | serine hydrolase activity(GO:0017171) |
0.1 | 0.1 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.1 | 0.6 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.5 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 0.7 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.5 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 0.4 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.1 | 1.7 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.1 | 0.3 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 0.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 1.1 | GO:0008047 | enzyme activator activity(GO:0008047) |
0.1 | 0.9 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.1 | 0.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.6 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.1 | 0.3 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.1 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.9 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.7 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 8.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.1 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.4 | GO:0015926 | glucosidase activity(GO:0015926) |
0.1 | 0.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 0.7 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.1 | 0.2 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.1 | 4.5 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 1.4 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.7 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 1.0 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.1 | 0.7 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.1 | 0.6 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 0.3 | GO:0016829 | lyase activity(GO:0016829) |
0.1 | 22.4 | GO:0008270 | zinc ion binding(GO:0008270) |
0.1 | 1.7 | GO:0005506 | iron ion binding(GO:0005506) |
0.1 | 2.5 | GO:0050662 | coenzyme binding(GO:0050662) |
0.1 | 1.7 | GO:0016298 | lipase activity(GO:0016298) |
0.1 | 0.2 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.1 | 0.2 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.5 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.1 | 0.2 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.1 | 10.3 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.1 | 0.2 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 0.4 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 0.3 | GO:0008252 | nucleotidase activity(GO:0008252) 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.3 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.3 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 185.6 | GO:0005515 | protein binding(GO:0005515) |
0.1 | 0.6 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.1 | 0.9 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.1 | 0.3 | GO:0016887 | ATPase activity(GO:0016887) |
0.1 | 16.3 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 0.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.5 | GO:0016817 | hydrolase activity, acting on acid anhydrides(GO:0016817) |
0.1 | 0.1 | GO:0004428 | obsolete inositol or phosphatidylinositol kinase activity(GO:0004428) |
0.1 | 0.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 1.0 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
0.1 | 0.2 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.1 | 0.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.4 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 0.2 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 0.1 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 0.3 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 0.1 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
0.1 | 5.8 | GO:0016787 | hydrolase activity(GO:0016787) |
0.1 | 0.1 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 0.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 0.8 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.1 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.1 | 0.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 1.0 | GO:0019842 | vitamin binding(GO:0019842) |
0.1 | 37.4 | GO:0005488 | binding(GO:0005488) |
0.1 | 0.2 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.1 | 0.1 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.0 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.4 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.4 | GO:0005231 | excitatory extracellular ligand-gated ion channel activity(GO:0005231) |
0.0 | 0.2 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.0 | 25.1 | GO:0060089 | receptor activity(GO:0004872) molecular transducer activity(GO:0060089) |
0.0 | 0.1 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.0 | 0.0 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.0 | 0.7 | GO:0016782 | transferase activity, transferring sulfur-containing groups(GO:0016782) |
0.0 | 0.8 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 0.3 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 13.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.8 | 0.8 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.8 | 2.5 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.6 | 36.5 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.6 | 1.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.6 | 14.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.6 | 11.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.5 | 8.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.5 | 1.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.5 | 6.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.5 | 14.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.5 | 11.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.5 | 12.9 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.5 | 6.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.5 | 10.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.5 | 16.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.4 | 2.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 14.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.4 | 10.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.4 | 7.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.4 | 3.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.4 | 2.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.4 | 4.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.4 | 2.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.4 | 4.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.4 | 0.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.4 | 8.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.4 | 3.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.4 | 14.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.4 | 2.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.4 | 5.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.4 | 6.5 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.4 | 1.5 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.4 | 2.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.4 | 4.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.4 | 3.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.4 | 1.8 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 1.4 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.3 | 1.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.3 | 2.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 8.2 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.3 | 12.2 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.3 | 4.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.3 | 6.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.3 | 1.3 | PID ENDOTHELIN PATHWAY | Endothelins |
0.3 | 6.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.3 | 7.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.3 | 6.5 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.3 | 14.7 | PID P73PATHWAY | p73 transcription factor network |
0.3 | 3.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.3 | 0.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.3 | 6.3 | PID FOXO PATHWAY | FoxO family signaling |
0.3 | 5.6 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.3 | 1.5 | PID CDC42 PATHWAY | CDC42 signaling events |
0.3 | 0.6 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.3 | 1.8 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.3 | 3.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.3 | 7.2 | PID ATR PATHWAY | ATR signaling pathway |
0.3 | 1.4 | PID IFNG PATHWAY | IFN-gamma pathway |
0.3 | 9.9 | PID BMP PATHWAY | BMP receptor signaling |
0.3 | 12.7 | PID E2F PATHWAY | E2F transcription factor network |
0.3 | 7.2 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.3 | 5.0 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.3 | 4.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.3 | 5.1 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.3 | 4.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.3 | 1.0 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.3 | 3.9 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.3 | 3.3 | PID BCR 5PATHWAY | BCR signaling pathway |
0.3 | 3.8 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 3.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 4.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 1.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 1.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 3.9 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 0.5 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 4.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 10.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 1.7 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.2 | 0.2 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.2 | 5.2 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 1.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 3.6 | ST ADRENERGIC | Adrenergic Pathway |
0.2 | 10.9 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.2 | 6.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 5.8 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 4.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.2 | 2.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.2 | 1.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 0.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 1.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 4.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 0.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 3.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 1.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 1.7 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 3.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 2.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 0.6 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 5.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 3.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 1.6 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 0.5 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 1.0 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.2 | 1.4 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 0.3 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 1.5 | PID ATM PATHWAY | ATM pathway |
0.2 | 4.0 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.2 | 1.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 1.8 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 3.0 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 0.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 1.3 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 0.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 2.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 0.6 | PID BARD1 PATHWAY | BARD1 signaling events |
0.2 | 0.5 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 3.1 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 0.9 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 7.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 4.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 1.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 3.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 2.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.8 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 1.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 2.0 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 2.4 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 0.6 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 1.0 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.8 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 0.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 0.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 1.4 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 2.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 0.2 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 0.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 0.7 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 0.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 3.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 2.5 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 1.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 1.7 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.4 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 1.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.9 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 1.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 1.0 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 0.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 1.0 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 10.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 1.0 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 0.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 0.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 6.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.0 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 4.0 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.9 | 10.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.9 | 2.7 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.8 | 18.0 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.7 | 1.5 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.7 | 3.4 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.7 | 0.7 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.6 | 3.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.6 | 0.6 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.6 | 1.8 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.6 | 15.9 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.6 | 3.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.6 | 13.0 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.6 | 5.1 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.6 | 0.6 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.6 | 9.6 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.6 | 6.2 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.5 | 2.2 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.5 | 6.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.5 | 3.2 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.5 | 7.8 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.5 | 4.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.5 | 6.8 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.5 | 0.5 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.5 | 17.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.5 | 11.5 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.5 | 5.5 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.5 | 27.8 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.5 | 1.0 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.5 | 0.9 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.4 | 7.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.4 | 0.4 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.4 | 8.0 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.4 | 7.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.4 | 0.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.4 | 6.0 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.4 | 4.7 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.4 | 2.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.4 | 1.7 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.4 | 2.9 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.4 | 3.2 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.4 | 3.1 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.4 | 1.6 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.4 | 4.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.4 | 5.1 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.4 | 7.0 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.4 | 5.1 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.4 | 7.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.4 | 1.5 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.4 | 4.2 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.4 | 2.3 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.4 | 8.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.3 | 16.3 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.3 | 5.9 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.3 | 1.4 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.3 | 15.8 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.3 | 7.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.3 | 9.0 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.3 | 10.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.3 | 4.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.3 | 1.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.3 | 1.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.3 | 13.8 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.3 | 4.8 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.3 | 6.1 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.3 | 3.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.3 | 1.9 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.3 | 1.0 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.3 | 7.9 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.3 | 5.7 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.3 | 0.9 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.3 | 6.2 | REACTOME M G1 TRANSITION | Genes involved in M/G1 Transition |
0.3 | 28.8 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.3 | 0.9 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.3 | 4.9 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.3 | 2.8 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.3 | 3.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.3 | 3.0 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.3 | 2.4 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.3 | 6.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.3 | 4.7 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.3 | 2.6 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.3 | 29.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 1.5 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.3 | 7.0 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.3 | 3.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.3 | 5.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.3 | 3.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 4.0 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.3 | 3.4 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.3 | 2.3 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.3 | 5.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.3 | 0.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.3 | 15.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.3 | 20.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.3 | 8.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 0.3 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.3 | 4.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.3 | 7.1 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.3 | 3.5 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.3 | 3.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.3 | 3.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.3 | 0.3 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.3 | 5.8 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.3 | 1.0 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.3 | 1.6 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.3 | 0.5 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 0.3 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.3 | 2.1 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.3 | 4.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.3 | 7.1 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.3 | 9.1 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.3 | 1.5 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.3 | 2.8 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.2 | 2.5 | REACTOME G1 S TRANSITION | Genes involved in G1/S Transition |
0.2 | 0.5 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.2 | 4.4 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 2.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.2 | 20.8 | REACTOME TRANSLATION | Genes involved in Translation |
0.2 | 6.8 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.2 | 3.7 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.2 | 2.1 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.2 | 1.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 1.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 8.6 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 3.0 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.2 | 3.2 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.2 | 2.2 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.2 | 0.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 3.8 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 12.7 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.2 | 2.2 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.2 | 3.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 2.4 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 1.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.2 | 3.2 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.2 | 2.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.2 | 0.2 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.2 | 63.5 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.2 | 5.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 1.9 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.2 | 6.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.2 | 2.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 1.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.2 | 1.9 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.2 | 1.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.2 | 2.2 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.2 | 2.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 2.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 2.0 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.2 | 1.4 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.2 | 8.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 3.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 3.9 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 15.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 0.8 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.2 | 1.7 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 6.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 1.1 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.2 | 0.6 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.2 | 1.9 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 0.9 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.2 | 8.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 0.4 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.2 | 1.8 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.2 | 0.5 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.2 | 2.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 2.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 1.4 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 3.0 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 4.0 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.2 | 2.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 0.7 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.2 | 0.5 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.2 | 2.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 2.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 0.3 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.2 | 1.3 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.2 | 1.8 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 3.2 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 2.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 0.6 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.2 | 2.6 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 0.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 17.5 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 1.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 1.6 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.2 | 0.5 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.2 | 0.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.2 | 5.5 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.2 | 2.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 3.8 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 0.3 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.1 | 1.8 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 7.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 2.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 7.3 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 1.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 0.8 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 2.8 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 0.8 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 1.6 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.1 | 0.9 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 0.9 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 1.7 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 0.6 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 1.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 1.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 6.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 1.8 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 0.7 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 1.1 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.1 | 1.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 4.2 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.1 | 1.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 1.5 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.1 | 1.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 1.2 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 2.9 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 1.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 0.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 1.6 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.1 | 2.3 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 2.9 | REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION | Genes involved in Post-translational protein modification |
0.1 | 1.1 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 1.1 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.1 | 1.0 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 0.5 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 2.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 0.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 1.0 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 9.1 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.1 | 1.0 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 1.4 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 1.8 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 5.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 1.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.1 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 1.1 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 2.1 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 1.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 1.8 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 2.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.5 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 0.1 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 0.4 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 3.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.4 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
0.1 | 0.5 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 0.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 0.5 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 0.4 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 0.7 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.1 | 0.8 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 1.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 0.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 3.1 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 0.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 2.6 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.6 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.3 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.0 | 0.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.3 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.6 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.0 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.0 | 0.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 1.1 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 1.7 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
0.0 | 0.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.0 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.0 | 0.0 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 4.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |